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ABSTRACT 
 
 
 L-3,4 dihidroxyphenylalanine (l-DOPA) strongly stimulates motor activity in 
parkinsonian patients and animal models of Parkinson's disease. Severe striatal dopamine 
(DA) loss characterizes Parkinson's disease and its animal models. Given the canonical 
rate model of Parkinson's Disease pathophysiology based on differences in DA 
pharmacology manifesting as electrophysiological differences in striatal projection 
neuron (SPN) spike rates, SPNs should increase spiking during the motor response to l-
DOPA. In fact, stimulating specific subsets of these neurons to spike in freely-moving 
wild type and parkinsonian animals causes or inhibits motor activity as predicted. 
However, pharmacological effects of DA deficiency, let alone those of DA replacement, 
on SPN spiking activity in freely-moving animals are poorly studied and ultimately 
unknown. Showing the activity of SPNs of both in-/direct pathways may help elucidate 
mechanisms by which l-DOPA increases motor activity to normal and sometimes 
abnormal levels; such mechanistic information would advance understanding about how 
DA is such a potent motor stimulant.  
 
To this end, I devised a Top-hat u-array (with microdrive) for recording in the 
striatum while stimulating the reticulated substantia nigra. Using my micro-array, I tested 
l-DOPA's acute effect on SPN spiking activity within contexts that varied in DA 
deficiency according to the Pitx3Null mouse's Parkinson's-like gradient of striatal DA 
denervation. Evidently, chronic DA denervation renders SPNs hyper-responsive to l-
DOPA and a D1 agonist, SKF 81297, as indicated by exaggerated SPN spike rate 
responses biased by low baselines in Pitx3Null mice compared to wild-type mice. 
However, this may be a motor network effect on spiking as it was found in both dorsal 
(DA-denervated) and non-dorsal (having residual DA) Pitx3Null striatal regions. 
Furthermore, antidromically identifying dorsal SPNs allowed us to putatively distinguish 
a particularly relevant subset (striatonigral, D1-SPNs or d[irect]SPNs) known to elicit 
movement; serendipitously we also identified putative fibers of passage that strongly 
resembled striatal interneurons. D1-SPNs in Pitx3Null animals had baselines about an 
order of magnitude significantly below those in wild-type, and all increased firing more 
so in Pitx3Null than wild-type mice after drug injections, which lends some credence to 
the hypothesis that direct pathway SPNs are hyper-responsive during l-DOPA-induced 
normal and abnormal motor behavior secondary to DA depletion. Furthermore, they 
uncover a need to incorporate more neural factors in explaining electrophysiological 
effects attributable to DA denervation and restoration pharmacology. The latter data 
(putative fibers) tempt the interpretation that cortical axons of passage are being mistaken 
for striatal fast-spiking interneurons in the literature more often than not. 
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CHAPTER 1.    INTRODUCTION 
 
 
Aim 1: Chart the Effect of DA Agonists on MSN Firing Rates over Varying Levels 
of DA Deficiency 
 
In order to contrast the spiking effects of DA agonists in the context of DA 
deficiency against those of WT mice and against the non-dorsal Pitx3Null (DA-
sufficient) context, we will use extracellular single-neuron recording during freely-
moving behavior. 
 
• Aim 1a. To contrast l-DOPA's effect on dorsal SPN spiking in Pitx3Null mice 
against that of WT during free behavior. Preliminary data support expectations. 
 
• Aim 1b. To contrast the effect of D1 agonist, SKF 81297, on dorsal SPN spiking 
in Pitx3Null mice against that of WT during free behavior. D1 agonism also 
accompanies increased normal and abnormal motor activity in this and other 
models of DA responsiveness in the DA deficient context (Li&Zhou, 2013; 
Bishop et al, 2005.) 
 
• Aim 1c. To correlate SPN rate-increases with dorsoventral recording depth to 
show an effect of DA deficiency on SPN spike rates. 
 
 
Aim 2: Chart the Effect of DA Agonists on Identified Striatonigral SPNs over 
Varying Levels of DA Deficiency 
 
In an effort to show that most cells increasing firing during movement are indeed 
D1-SPNs, we will perform separate recordings mirroring those above and afterward 
identify putative D1-SPNs. Since D2-SPNs do not have excitable fibers in the substantia 
nigra reticulata, spikes antidromically elicited from that region putatively identify D1-
SPNs as striatonigral. 
 
• Aim 2a. To contrast l-DOPA's effect on dorsal D1-SPN spiking in Pitx3Null mice 
against WT during free behavior.  
 
• Aim 2b. To contrast D1agonist's effect on dorsal D1-SPN spiking in Pitx3Null 
mice against WT during free behavior. 
 
 
Aim 3. To Get Lucky and Find a Random Phenomenon That Upends My 
Understanding of FSI Identification  
 
Striatal FSIs are routinely identified by their relatively high rate and narrow waveshape; 
however, the serendipitous discovery of their antidromic spiking evidence indicates that they 
might be fibers of passage. 
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• Aim 3a. To collate antidromic evidence for recording striatal fibers of passage; 
characterize said waveforms and their corresponding units. 
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CHAPTER 2.    LITERATURE REVIEW 
 
 
Rodent-Based Research of Parkinson’s Disease 
 
 
Parkinson's disease and treatment 
 
At autopsy, Parkinson's Disease (PD) patients show an especially marked 
degeneration of the nigrostriatal fibers that supply the striatum with dopamine (DA). 
(Kish et al. 1987 or 1988; Hornykiewicz 2001; Kowdoer et al. 2013 ). This otherwise 
intense striatal DA innervation (from the compact substantia nigra) complements heavy 
striatal DA receptor expression (Levey et al 1993; Yung et al 1995). Striatal DA loss 
invariably precipitates hypokinesia once it reaches ~80% (Kim et al., 2000 see also Fig. 4 
from Schwarting and Huston, 1996) and is proposed to induce a hypersensitivity to 
dopamine (Cenci & Konradi, 2010). After DA depletion, DA agonism elicits cellular 
markers (e.g. ERK, delta/FosB) of supersensitive dopamine D1 receptor stimulation 
(Gerfen et al, 2002; Pavon et al, 2006; Corvol et al, 2004) as it stimulates increases in 
both ab-/normal motor activity (Francardo & Cenci, 2014; Li et al, 2015). 
 
The most common PD treatment is DA replacement therapy using l-3,4-
dihydroxyphenylalanine (l-DOPA) because of its efficacy in stimulating motor activity 
(Olanow et al, 2009). In addition to normal motor activity, it may eventually induce 
hyperkinetic side effects, known as l-DOPA-induced dyskinesias (Olanow et al, 2009, 
Bastide et al., 2015). During l-DOPA's effect on behavior, it affects DA deficient striatal 
information processing, but this is poorly characterized (Iversen, 2010, pg 438), which is 
one striking reason for a continued focus on the behavioral and physiological 
manifestations of DA pharmacology in the context of DA loss (Olanow et al, 2009). 
 
 
Basal ganglia neurophysiology: the canonical model 
 
The striatum, a key component of the basal ganglia (BG) motor control circuit, is 
thought to be directly responsible for the motor symptoms of PD and of PD treatment 
(Hornykiewicz 2001; Franco & Turner 2012). The striatum is the BG structure that 
processes the majority of the BG's synaptic input, which is sent downstream via two 
distinct output pathways. One is the direct pathway in which dopamine D1 receptor-
expressing striatal projection neurons (D1-SPN, a.k.a. D1 striatal spiny projection 
neuron, D1-SSPN, D1 medium spiny neuron, D1-MSN, and dSPN) can ultimately 
activate movement via spiking. The other is the indirect pathway in which dopamine D2 
receptor-expressing SPNs (D2-SPN, etc, and iSPN) can ultimately inhibit movement via 
spiking (Kravitz et al, 2010). These downstream effects of spiking on behavior operate in 
both intact and DA-lesioned mice (Kravitz et al, 2010 ).  
 
Mechanistically, these phenomena are interpreted most often via the canonical 
rate model of the BG explained thus: both cell types release GABA but have opposing 
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effects due to the nuclei into which they synapse. Direct pathway SPN spikes disinhibit 
thalamocortical motor networks (allowing behavior) by directly inhibiting BG output 
nuclei, e.g. the substantia nigra reticuluata (SNr) (Kravitz et al, 2010; Freeze et al. 2013). 
Conversely, indirect pathway SPNs indirectly inhibit thalamocortical motor networks, by 
synapsing on intermediate inhibitory BG nodes; synapsing into these nodes reverses the 
polarity of their effect on downstream neuronal, and ultimately behavioral, activity. By 
way of example, specific D2-SPN activation has been shown to cease movements 
(Kravitz et al, 2010, Sano et al.,2013); this is interpreted canonically as inhibiting an 
intermediate inhibitory nucleus, which disinhibits the (inhibitory) SNr ultimately 
rendering thalamocortical motor nuclei further inhibited and reducing movement. Overall 
then, increases in D1-SPN spiking promote movement via the direct pathway, and 
increases in D2-SPN spiking inhibit it via the indirect pathway.  
 
 
SPN neurophysiology in DA denervated conditions 
 
Understanding what role stimulation of DA receptors on SPNs plays in their 
spiking might reveal mechanisms underlying l-DOPA's cell-level effects that accompany 
motor activity and could have a bearing on the interpretation of DA's function in the 
normal and pathological BG. Published results are interpreted to affect spiking indirectly 
through networks and/or are inconsistent. For example, in vitro SPN recordings from 
DA-lesioned animals are generally interpreted in terms of effects on corticostriatal 
glutamate release (reduced by aberrant D2 signaling after DA denervation and rescued by 
l-DOPA; Picconi et al, 2004) and long-term synaptic changes (aberrant Ca2+ currents 
after DA depletion; Prieto et al, 2009), whereas the canonical model is more directly 
invoked to explain in vivo anesthetized results in terms of spike output (increased 
background spiking after DA depletion normalized by l-DOPA; Kita&Kita, 2011a, b). 
However, the fact that anesthetized (and in vitro) SPNs show drastically different 
spontaneous firing properties and membrane potential states than in awake animals 
(namely, less variable rates and bimodal resting membrane voltage; Mahon et al, 2006; 
Kish et al, 1999; Rebec, 1998) highlights the importance of behaving animal recordings 
in exploring the effects of DA denervation on SPN spiking during behavior. 
Despite the seemingly straightforward connection between direct stimulation of D1-SPNs 
causing their spiking and consequent motor activity (Kravitz et al, 2010) and 
supersensitive DA receptors (which SPNs likely express more heavily than any other 
brain area due to their baseline expression being many-fold higher; see e.g. Fig. 2 of 
Delis et al., 2013) possibly being one cause of LID (Cenci & Konradi, 2010), effects of 
DA agonism on DA-deficient SPN spiking during such behavior is poorly researched. 
Such recordings are rare in primates (not one according to the following review: Boraud 
et al., 2002, at least one thereafter: Liang et al., 2008, Singh et al., 2015, 2016) and rare 
and conflicting in rodents (Iversen, 2010, pg. 438; Kish et al, 1999; Chen et al, 2001). 
Nonetheless, knowing these receptor and cell level events is necessary if one wants a full 
account of BG functionality to explain l-DOPA's behavioral effects in enough 
mechanistic detail to refine understanding of how SPN activity informs behavior.  
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Since specifically D1-SPN rate increases induce motor behavior (in both DA un-
/lesioned conditions; Kravitz et al, 2010), and DA denervation of striatal cells sensitizes 
the BG to do the same under l-DOPA (thus DA) agonism (Corvol et al, 2004; Cenci and 
Konradi, 2010), then it is expected that at least part of the underlying mechanism of 
motor activity induction by l-DOPA would be the rendering of D1-SPNs hyper-
responsive to DA agonism by DA denervation (Feyder et al., 2011, Iversen, 2010, pg. 
438, and Murer & Moratalla, 2011). 
 
To this end, we recorded SPN responses to l-DOPA and D1 agonist, SKF-81297 
in DA deficient (Pitx3Null dorsal striatum, defined further in Methods) and DA sufficient 
(Pitx3Null non-dorsal and WT dorsal striata) conditions. We further identified a subset of 
striatonigral SPNs antidromically in order to begin interpreting the results from the in-
/direct pathways perspective. 
 
The Pitx3Null mouse models l-DOPA-induced motor activity. This is because it 
has a chronic, spatially restricted, dorsoventral DA deficiency gradient and a robust ab-
/normal motor response to l-DOPA that is absent in WT animals (Francardo & Cenci, 
2014; Hwang et al, 2005). Contrasting these against WT mice, we looked for 
electrophysiological evidence consistent with the predominant hypothesis (see e.g. Cenci 
and Konradi, 2010 and Murer & Moratalla, 2011) that l-DOPA induces motor activity via 
rate increases in D1-SPNs. By testing SPN responses to DA agonism, we expected to 
discover a spiking mechanism putatively underlying LIM. Specifically, we looked for 
any evidence that DA deficiency would be associated with a change in baseline rate 
between groups before we tested the hypothesis that DA-denervated SPNs (i.e. from 
dorsal Pitx3Null mice striata) show exaggerated spiking responses during their DA-
agonism-induced motor activity superseding those of dorsal WT SPNs (fully DA 
innervated). In addition, we tested the hypothesis that dorsal Pitx3Null SPNs increased 
spiking in response to DA agonism more so than non-dorsal Pitx3Null (less DA 
denervated) SPNs. Finally, we re-tested the first hypothesis in a subset of antidromically 
identified SPNs.  
 
 
Mistaking Fibers of Passage for Fast-Spiking Striatal Interneurons 
 
Electrophysiologically recording the striatal neurons of rodents is a commonly 
performed technique in the neuroscience literature concerning normal and diseased brain 
function (e.g. Parkinson's disease, drugs of abuse). (Gittis et al, 2011, Kubota et al, 2009, 
Lee et al, 2017, o’Hare et al, 2017, Sagot & Zhou, submitted) Aside from the inherent 
technical difficulties of electrophysiological recordings, focusing research questions on a 
particular subtype of neuron further decreases the likelihood of sampling from a 
population of interest. According to many publications (Graveland & Difiglia 1985, Saka 
2002, Rymar et al 2004), interneurons represent <5% of total striatal neurons, which can 
further be broken down into different interneuron types; e.g. tonically active neurons 
(TANs), and fast-spiking interneurons (FSIs), also known as parvalbumin-positive (PV+) 
interneurons. Luk and Sadikot, 2001, report that PV+ interneurons make up only 0.7% of 
striatal interneurons. Thus attempts to record these would at least initially be expected to 
 6 
have much fewer opportunities to do so and be reflected in unbiased samples at 
approximately the same rate. 
 
However, in vivo electrophysiologists have reported FSI proportions in striatal 
samples to account for 7-30%. (Barnes 2005, Kubota et al, 2009, Hernandez et al, 2013, 
Berke et al 2004 and 2008, Gage et al, 2010, Schmitzer Torbert and Redish 2009, Lee et 
al, 2017) When unintentional (as opposed to e.g. Mallet, 2005), this obvious discrepancy 
has been hypothesized to result from their biased distribution towards the dorsolateral 
striatum (Berke 2011) and a general facility for recording data from neurons having 
larger somata and higher spike rates due to their more obvious presence during spike 
sampling before recording. (Heinricher in Microelectrode Recording in Movement 
Disorder Surgery, 2004 ed.) 
 
Identification metrics in these cases have used primarily waveshape, and some 
combination of firing rates, ISI histograms, autocorrelograms,or peri-event rasters 
(Barnes et al, 2005, Mallet 2005 and 2006, Kubota 2009, Schmitzer Torbert and Redish 
2009, Tepper, 2010, Gittis et al, 2011, o’Hare et al, 2017), but these criteria are 
inconsistently seen, reflecting the lack of knowledge over clearly distinguishing FSI traits 
in vivo; unambiguous identification is rare (Tepper and Koos, 2017). Thus resolving the 
identity of these units potentially stands to shed new light on previous conclusions, e.g. 
the task-relevance of FSIs (Berke et al., 2004, Kubota et al, 2009, Tepper & Koos, 2017) 
 
Some hint of their identity came accidentally when, during antidromic 
identification of direct pathway SPNs, I recorded antidromic responses in the striatum 
having the waveshapes and ISI characteristics much more commonly associated with 
FSIs. Other evidence supports this interpretation: response latencies predicted by 
theoretical expectations of myelinated axons (Jinnai & Matsuda, 1979) and putative 
fibers clustered with up to 4 others (as reported: Berke, 2008) These tempt the 
interpretation that these are better explained as cortical fibers of passage, however more 
research should confirm this hypothesis. 
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CHAPTER 3.    METHODS 
 
 
Top-Hat U-Array: Design, Fabrication, and Use 
 
In order to record neural activity from freely moving animals, a device must 
effectively host the interface between the brain and the recording equipment, must 
minimize interference with the animal’s behavior (most likely being lightweight, ~10% 
of body weight) and be able to withstand months of implantation on the animal’s head, 
and –if the neural coverage is not sufficient– must reposition electrodes in order to 
optimize recordings as well. Usually this device is referred to as a microarray, with or 
without a microdrive for repositioning electrodes. 
 
In order to accomplish these using as few and inexpensive resources as possible, I 
designed a microarray I call the “Top-hat u-array’ due to its appearance on the animal 
once implanted. (Figure 1) The design, fabrication, and use of this microarray are 
described here. 
 
 
Top-hat u-array design 
 
In designing the array, considering the brain areas from which one will record or 
stimulate forces the device to have certain parameters since volume and component 
proximity are limited; in our case, the simultaneous recording/stimulation (using 
electrode sets inside stabilizing tubes having < 0.26 mm. outer diameter) from a 
maximum of four locations having inter-site spacing > 0.5 mm. were made possible in 
the rostral cortex, striatum (str), and substantia nigra pars reticulata (SNr) of one 
hemisphere of a mouse. Flexibility of the design for starting materials is maintained by 
using small –compared to the entire available volume–, modular pieces (e.g. tubes, 
screws, springs, etc. as opposed to 3D printed parts). Flexibility for accommodating other 
brain areas and hemispheres is maintained by pre-registering the top hat’s components –
with respect to one another and ultimately to the skull–, i.e. 1:1 placement of array 
components into a base that doubles as a “skull map” (a common frame of reference) 
without having to place everything relative to each other during surgery. Flexibility in the 
dorsoventral positioning of electrodes is maintained by including a microdrive 
mechanism, which in our case was done by registering another skull map on top of the 
first in order to subtractively form “feet” that interface between the drive screw and the 
carrying tube. (Figure 2 showcases a completed Top-hat minus debris shield and ground 
wire.) 
 
A miniature connector and interface, or breakout, board for connecting electrodes 
to the input connector pins and ultimately to the recording system was in our case 
essential in terms of minimizing weight, facilitating input connections, and facilitating 
registration to the stereotax during implantation. The EIB-16 from Neuralynx we used 
might be unable  
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Figure 1 Implanted Top-Hat U-Array.  
Upper left and upper middle – the implantation steps preceding recovery during ground 
wire placement. Upper right – the animal grooming its paws after recovery. Lower left – 
the animal roaming its cage after recovery. Lower right – close-up of implant 
highlighting placement with respect to skull, dental cement anchoring to screws, 
windows in debris shield, and translucence  
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Figure 2. Feet Interface Microdrives with Base.  
Upper left – an assembled microdrive set with connector anchored to base. Upper right – 
shield tubing during placement (although this step is normally done after electrode 
placement, gluing, and pinning): window seen between thumb and forefinger on right. 
Lower left – preparing to insert polytrodes into carrier tubes. Lower middle and right – 
close-ups of assembled microdrive set and anchored connector (stimulating electrode set 
clearer although its slight protrusion is problematic due to fragility of fine tips)  
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to be improved upon, and in our case doubles as a cover for the Top-hat u-array, keeping 
most environmental debris out for longer than other arrangements. (Furthermore, they 
were re-usable at least once, if not multiple times until obvious defects arose or the 
connector did not hold its mate >5 minutes during animal behavior.)  
 
Similarly, in such an arrangement, a transparent and durable shield should protect 
the mechanisms and wiring; in our case, clear, cylindrical, plastic tubing (metallic wire 
mesh may also work to a slightly lesser extent and allow for electromagnetic shielding 
when attached to ground) that fits snugly around the entire contraption resting atop the 
base is essential for excluding debris and interference from the animal’s movement. 
However, the ability to insert tools for troubleshooting through this wall comes at the cost 
of excluding debris (but can facilitate rinsing if appropriately situated), so optimizing the 
size and placement of windows in the shield should be carefully considered. (Figure 2, 
upper right) 
 
 
Polytrode fabrication  
 
Polytrodes (electrodes wrapped together in various numbers) are necessary in 
order to complete the array; fabricating them before the microarray affords an economy 
of scale (provided the protocol yields acceptable work-product) since they are less labor 
intensive (and thus easier to make in bulk) and because having them available allows one 
to focus on finishing the microarray once begun. 
 
The protocol of Liao et al, 2011, was adapted to our purposes (since we used 
~12.5 um nichrome wire from Kanthal Palm Coast, Palm Beach, FL); specifically 
starting from the proposition that 4 wires having 25 um outer diameter can withstand 60 
turns/cm without failing, and assuming a linear relationship between the number of turns 
and the number and diameter of wires to be included in the polytrode, then twice the 
number of wires at half the diameter should yield the same acceptable turn ratio. An 
intuitive way to consider this approximation is that one could theoretically cut each 25 
um wire into two 12.5 um wires without disturbing too much the turn ratio; thus, eight 
~12.5 um wires should withstand about 60 turns/cm. (Figure 3) 
 
(More electrodes than four were used per polytrode since preliminary results 
showed non-orthogonal –highly correlated– data on four non-splayed electrodes, i.e. 
overlapping data, rendering tetrode utility comparable to a single electrode. At times 8 
and sometimes 6 wires were used, which helped splay some wires from the others and 
allowed us to use only the most orthogonal data during spike sorting. Incidentally, 
introducing splay manually had a similar though less reliable effect, although splaying 
should generally not precede insertion of the polytrode through its stabilizing or carrying 
tube, i.e. the final steps.)  
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Figure 3. Capture and Spinning of Polytrode Wires.  
Upper left and right – capture of wetted polytrode wires within polyethylene-tipped 
hemostats. Lower left – hemostats suspended above magnetic stirrer on lowest spin 
setting (~1 rev./sec). Lower right – hemostats set held in polyethylene tubing loop (away 
from stirrer) unspinning freely until rest  
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Taking the number of wires to be turned together into the polytrode was done by 
folding an extended piece of nichrome as many times as necessary to create the desired 
multiplicity at ~15 cm length (i.e. ~90 cm for a 6-trode, 120 for n 8-trode), then running 
the bunch under a stream of water while pinching the tip with more folds (i.e. leaving one 
tip loose to be straightened uniformly by the water); once wires stayed in a smooth 
bundle, this pinched section was transferred carefully to straight-tipped forceps to be 
hung by its handle on two appropriately spaced and sized knobs. Bundling the wires at 
the other tip may require another run under water, but once both tips are held each by 
straight-tipped forceps (one pair of which is hooked onto the knobs), then a magnetic 
stirrer is placed underneath the lower pair and centered with respect to it. The turn ratio 
then translates well into the rate at which the polytrode is spun: 1 minute/cm for turn 
ratios of 60/cm. 
 
Once the polytrode has the desired number of turns, the magnetic stirrer is 
removed and the polytrode allowed to un-spin and re-spin until coming to rest (Figure 3, 
lower right), at which point it is safe to remove the forceps and store the polytrode 
somewhere that dust and static are minimized (for ease of array fabrication). 
 
 
Top-hat u-array fabrication 
 
 
Registering the skull base to the connector (interface board) and feet  
 
A picture and description of parts used in the Top-hat u-array is found in Figure 
4.   
 
(In order to facilitate fixture, before gluing, of components into the plastic, drill 
bit diameters should be rated for widths at least 10-15um smaller than the outer diameter 
of the tube expected to be placed through the resulting hole, e.g. 0.25 mm. for a 31 ga 
(0.26 mm outer diameter) tube such that insertion is smooth yet temporarily held in place 
without gluing.) 
 
In the first step of Top-hat u-array fabrication, two polycarbonate pieces of 
sufficient size to accommodate the footprint of the shielding tube (~2x2 cm) are 
registered to each other by means of two holes simultaneously precision drilled 
(MicroLux, Micro-Mark, Berkeley Heights, NJ) at opposite corners of both layers –one 
layer on top of the other– and inserting appropriately sized rigid tubing until flush with at 
least one layer of the two.  
 
(Measuring exact locations of sites on this two-layered piece can be difficult 
without having either markings in the microdrill’s retaining bars or preset markings on 
the piece itself; we used the former in order to avoid repeating the latter for every Top-
hat.) 
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Figure 4. Materials Useful in Top-Hat U-Array Fabrication.Upper left – 
precision drill press and guide bar (having metric notches unseen here). Upper middle – 
dissection microscope and fabrication platform having lighting. Upper left – stimulus 
isolator, impedance meter, and plating station. Lower left – precision tools and 
consumables. Lower right – microdrive and polytrode consumables.  
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Marking the anteropesterior (AP) and mediolateral (ML) locations of desired 
recordings is straightforward; define a center of the base (perhaps as bregma or lambda or 
some variant), then take each coordinate as an ordered pair –(x, y), where x = ML or AP 
coordinate, and y = the respective other– then carefully drill through both layers of 
polycarbonate using the drill bit corresponding to the outer diameter of the smallest 
carrying tube (in our case 0.25 mm, corresponding to the 31 ga tube). The resulting holes 
will eventually accommodate the carrying tube in the top layer and mark the guide tube 
location in the second layer. 
 
(Using smaller drill bits before larger in the fabrication process mitigates the 
impact of some drilling errors.) 
 
Without turning the piece over or separating the layers, drill eight holes 
appropriately sized (in our case, ~1.0 mm) to fit the drive screws (in our case, 00-90 
screws, 1.194 mm outer diameter) in an equilateral octagon around the center of the base, 
4 of which will be covered by interface board corners –2 of those being used for screwing 
the board to the base– and 4 of which will anchor the carrying tubes to the base and act as 
an actuator for the microdrive mechanism. The distance from the center to the screw 
holes should equal half the distance between the two screws that will anchor the interface 
board (in our case the two screw holes at opposite corners of the EIB-16, which have a 
center to center distance ~12.5 mm).  
 
 
Drilling out and fitting microdrive components 
 
Separate the layers; choose a top layer –for making feet that connect the carrying 
tube to the drive screws– and a bottom layer –as the base to hold guide tubes, anchoring 
screws, drive screws, and the shielding tube. 
 
The next largest dill bit (in our case, sufficient to snugly fit a 26 ga guide tube, 
~0.45 mm, for polytrodes and to fit a 20 ga for the stimulating electrode guide tube, ~0.9 
mm) is used to drill out the marked guide tube sites on the chosen bottom (base) layer. 
Drilling an extra hole within the perimeter will allow a ground wire (otherwise passed 
down around the edge of the base) to be passed directly through the base and provide 
another anchor point for dental cement during implantation. Guide tubes may then be 
glued having the desired protrusion from the base being careful to ensure that they are as 
parallel as possible to each other.  
 
On the same layer, a tap for the drive screws is used to carve into the 8 perimeter 
holes. These screws should be long enough (~ 25 mm in our case) to protrude from the 
bottom of the base (by ~6-8 mm in our case) in order to provide anchoring to the skull 
using dental cement. Although not all 8 need be used (accommodating up to 4 drive 
screws + 2 anchoring screws + optional other anchoring screw projections from base), 
whichever are used varies primarily according to the ease with which certain feet connect 
to the carrying tubes (in our case, the EIB connector orientation was necessarily also 
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considered). The final step on the base layer is to align guide tubes with respect to each 
other. 
 
As for the top layer, the primary concern is ensuring that whichever 4 (or fewer) 
of the 8 screw holes used to accommodate the drive screws, which hold the carrying tube 
feet, are designed and then fabricated without error; minimizing the distance between the 
drive screw and its carrying tube will ultimately maximize the downward force of the 
screw on the carrying tube, minimizing the chance to get stuck. Since it is much easier to 
drill out each drive screw hole than form the feet, the largest drill bit (in our case, 1.25 
mm) is used to drill out all 8 perimeter holes, and 4 (or fewer) feet are then designed by 
marking boundaries between them –e.g. using a fine-tipped felt pen or scalpel tip– then 
formed subtractively –i.e. by removing surrounding shards of plastic at first using 
diagonal pliers then by a razor under a dissecting microscope. It is critical here to 
carefully remove as much plastic as possible from around the carrying tube hole (in order 
to keep it from interfering with others during use on the animal) without risking the 
integrity of the hole. The area around the drive screw holes requires similar care since 
they may otherwise interfere with shield tube placement at the final step.  
 
(In either case, when a tube hole is compromised, superglue may carefully be 
applied either shortly thereafter or in the next step during the process of positioning 
carrying tubes inside guide tubes and affixing them to the feet, although be warned that 
superglue in such a confined space can easily cause more harm than good in such a 
delicate situation.) 
 
 
Assembling the microdrives 
 
Assembling the feet (once they are approximately shaped enough to be 
assembled) into the drive mechanisms can minimize damage to the feet during the final 
touches of their formation since they otherwise become much more difficult to hold once 
removed from one another. In order to assemble the feet, thread a drive screw (in our 
case, 3/8” 00-90 screw) downward through the foot’s drive screw hole and into a spring. 
Then using a fingertip to steady this combination on the tip of a screwdriver 
(approximately upside-down), begin screwing this screw into the drive screw hole on the 
base, i.e. that has been tapped. Perform the same for the remaining feet and drive 
screws/springs unless they interfere with each other enough to preclude removing further 
shards. (Figure 4, lower right, circled) 
 
Once the base holds all the microdrives, remove shards from the feet until they no 
longer interfere with each other upon use; inserting the carrying tubes through their holes 
into the guide tubes and screwing the drive screws as far as possible into the base can 
hold the feet in place to facilitate such removal.  
 
(Replacing gloves when handling the fine gauge tubes minimizes the chance that 
debris will block the tube during polytrode or stimulating electrode insertion.) 
 
 16 
Once the carrying tubes have been inserted into the guide tubes through their foot 
holes, they should be checked for patency using thin wire (in our case ~0.05-0.1 mm), 
and then glued to the feet while ensuring that their maximum extension and retraction do 
not interfere with the interface board or protrude too much. (In our case, guide tube 
patency was checked before precisely inserting the stimulating electrode set itself into the 
foot under the dissection microscope; carrying tubes were pre-pared in our case at 15 mm 
long to fit 10 mm long guide tubes and a presumed 17 mm EIB height) Ensure that at 
maximum extension the carrying tube does not exit the guide tube longer than ~0.3-0.5 
mm, the approximate depth of dura from the top of the skull. Applying some superglue 
around each carrying tube on top of its foot mitigates the risk that it will slide within its 
hole during drive screw retraction, but doing the same underneath the foot risks fastening 
the carrying tube to the guide tube, so this latter step is best done with the drive screw 
fully retracted. 
 
 
Anchoring the connector interface board and connecting polytrodes 
 
Next, the connector interface board can be anchored to the base. First threading 
the anchoring screw (in our case, 1” 00-90 screw, Fasteners and Metal Products Corp., 
Waltham, MA) through a nut, then the board, then another nut allows one to tighten the 
nuts around the board so that movement of the board in its final situation is minimized. 
Once this is done for one side of the board, that anchoring screw is threaded into its 
tapped hole in the base. 
 
Threading the second screw begins the same as the first, but the lower nut should 
only be tightened after this screw has been threaded into its anchoring hole (otherwise the 
screw might not tighten into the base but against the nut); serrated tweezers around the 
nut and a screwdriver to hold the screw in place are helpful here. More important in this 
step is the final height of interface board on each screw, which should be an equal 
distance from the base on both anchor points in order to minimize torsion on the 
connector board. 
 
Polytrodes are then inserted into their carrying tubes (or stabilizing tubes first if 
necessary: in our case polyimide tubing, Part No. MIL 38, Microprobes, Gaithersberg, 
MD) and extended sufficiently from the guide tube in order to allow ~1 mm of the entire 
tip to be splayed before being dipped in ethyl cyanocrylate (Jog et al, 2002) and dried for 
the final cut exposing the electrode wires uniformly. Finally, taking the guide tube tip as 
skull depth, the cut polytrode is lowered as far as possible in order to define the furthest 
ventral location from which to be recorded unless the highest point to be recorded is more 
critical. In either case, the carrying tube is not yet glued to its contents –nor, ideally, are 
the stabilizing tubes glued to theirs– before connecting all individual electrode wires 
(except ground and reference) to the connector board and checking for connectivity 
during gold-plating or waiting until gold-plating is complete. At this point the electrode 
wires are individually pinned to the interface board; a gentle tug on each wire after 
pinning ensures that it has not broken at the point of contact. (Figure 5) 
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Figure 5. Pinning Electrode Wires to Interface Board.Upper left – capturing 
polytrode for insertion into carrying tube. Upper right – inserting gold pin into interface 
board receptacle having wire inserted. Lower left – pinching gold pin to wire and into 
receptacle. Lower right – completed Top-hat u-array showing all wires and tubes finally 
situated.  
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Gold-plating protocol 
 
The gold-plating protocol essentially mirrors those in common use, but one extra 
step is borrowed from Ferguson et al, 2009 (whose protocol is otherwise exemplary): the 
addition of plating inhibitors in order to ultimately accomplish a “rice-like” texture on the 
electrode tip that reduces impedance without increasing site-exposure, i.e. increases 
sensitivity without sacrificing selectivity. Briefly, 1.125 mL of 1g/L PEG-8000 and 0.375 
mL non-cyanide gold-plating solution (gold-plating solution, Neuralynx, Bozeman, MT) 
are combined in a 1.5 mL centrifuge tube. In our case, a complementary connector 
having individual pre-connected output wires accessible for running current through each 
electrode individually is affixed to the interface board’s connector, the polytrodes are all 
lowered into the solution. The electrode tips are first “cleaned” (metal oxides reduced and 
some debris repelled) by passing the opposite current as used for plating, i.e. electrode 
being positive, using 0.1 uA (controlled by a stimulus isolator: in our case, WPI 365) for 
< 5 seconds. Next, the polarity is reversed, and plating proceeds through all electrodes in 
succession using the same current (0.1 uA) for up to 30 seconds during the first round 
and for progressively shorter durations thereafter until electrode impedance measured 
~50-100 kOhm; this often required longer duration pulses during successive rounds than 
those given in the reference. (Figure 6) 
 
Spritzing with alcohol will not ruin the tip and was used as an antiseptic just 
before surgery (checking the need for re-plating beforehand if waiting > 1 week for 
surgery). 
 
 
During surgery 
 
In order to ensure accurate placement into final coordinates, registering the array 
to the stereotaxic apparatus is essential. Without having to assume the entire array has 
been made with right angles in mind at every fitting and gluing step, it was useful in our 
case to simply use the connector as an anchor point to the stereotax’s holder arm and 
make slight adjustments there that optimized the colinearity of the guide tubes with 
respect to the arm (which assumes the guide tubes have been aligned with respect to each 
other), e.g. by holding the arm against a straightedge and comparing the guide tubes to 
the same edge. The anchor point consists of a customized screw-in extension to the 
holder arm that clamps onto the connector via a screw-on faceplate; although the screws 
must be tightened as little as possible, the force holding the Top-hat u-array should not be 
overcome by gentle tugs on the ground wire. (Figure 1) 
 
After preparing the animal for implantation following standard rodent surgical 
procedures –specifically after accurate formation of trephine holes for all necessary 
components (2 or 3 skull screws + up to 4 polytrode holes)–, the pre-registered array/arm 
combination is affixed to the stereotax, carefully lowered until guide tubes are ~1 cm 
above the skull, and sterile petrolatum or antibiotic ointment applied to each polytrode 
base at the guide tube (in order to prevent the entry of dental cement later). The main  
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Figure 6. Gold-Plating Electrodes.  
Styrofoam holding plating solution in centrifuge tube, impedance tester connected to wire 
in solution (green lead) and individual electrode (colored mating connector wires 
wrapped around stand arm), changing polarity on right to plating (from cleaning)  
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ground wire is then wrapped around a skull screw –as far from the polytrodes as possible 
in order to facilitate later work with them– allowing some slack in order to enable slight 
retractions in case polytrodes need to be slightly repositioned. 
 
In order to facilitate polytrode entry into the brain, it may be necessary to cut 
dura; in our case, the smallest syringe tip available having been slightly curved at the tip 
was used to pierce and retract dura, which requires careful monitoring of bleeding (and 
use of epinephrine and/or gelfoam and saline flushing / sterile swabbing as necessary). 
Taking note of the position on the stereotax ruler as each polytrode reaches the dura 
during penetration allows one to reconstruct (using the final position measurement) the 
depth that each polytrode has been placed below dura. Dental cement can then be draped 
from each guide tube at its protrusion from the base of the Top-hat u-array to its situation 
on the animal’s skull, and liberally applied to all skull screws and any available 
anchoring screw tips; ensuring that all locations having cement eventually connect via 
cement to all others reinforces the integrity of the entire interface. Allow the dental 
cement to harden to the touch before unscrewing the faceplate that holds the connector as 
gingerly as possible and returning the animal to a recovery cage. No special precautions 
are necessary for the animal’s wellbeing in the new cage except that it should be housed 
alone. 
 
 
Recovering Top-hat u-array parts 
 
Figure 7 pictures the Top-hat u-array after removal from a sacrificed animal. It is 
advisable to recover parts that are hard to find and/or expensive (in our case, the EIB-16 
and 1-inch screws). Pliers can easily remove most large chunks of dental cement that has 
not been soaked in methyacrylate for softening. Smaller chunk in the grooves of screws 
(and large chunks that threaten the integrity of fragile parts) can be softened or carefully 
removed using finer tools.  
 
It is also advisable to inspect the polytrode tips and protrusions (e.g. to inform 
depth estimates taken during recording), then unscrewing the microdrives –upward– to 
minimum protrusion, taking a measurement, and comparing to original parameters in 
order to check for evidence of drive, glue or tube failure before screwing downward to 
maximum protrusion for same. 
 
 
Pitx3Null Mouse Model 
 
Pitx3Null mice lack a functioning Pitx3 transcription factor, which ultimately 
leads to the death of the vast majority of SNc tyrosine hydroxylase positive (i.e. DA 
producing) neurons and DA receptor supersensitivity in the striatum (Hwang et al, 2005), 
while some VTA DA neurons are independent of Pitx3 and thus survive (Jacobs et al, 
2007; Hwang, 2003). This loss of DA neurons that would otherwise project to the dorsal 
striatum yields a dorsoventral DA denervation gradient in the striatum having the 
following 
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Figure 7. Recovered Top-Hat U-Array Used for Parameter Checks after 
Months of Implantation. 
Upper left and right – differing angles of whole Top-hat u-array pulled from skull after 
sacrifice Middle left – 10x magnification of stimulating electrode set tips Middle right – 
40x magnification of stimulating electrode set protruding from guide tube Lower left- 
40x magnification of stimulating electrode set tips Lower right – 40x magnification of 
polytrode tips protruding from base (splay only slightly larger than when implanted), 
reference wire accompanies lower polytrode deinsulated to 1 mm from tip.  
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characteristics: relative to WT siblings, the nucleus accumbens (ventral striatum) retains 
~40-80% of its releasable DA from ~30% of the midbrain DA-ergic axons; however, the 
dorsal striatum retains ~0-10% of its releasable DA from DA-ergic terminals totalling 
<10% of WT terminals (Smits et al 2007, Li & Zhou, 2013, Wei et al. 2013). This 
denervation gradient is associated with molecular markers of DA receptor 
supersensitivity in the dorsal striatum subsequent to l-DOPA in common with similar 
animal models (Francardo & Cenci, 2014). 
 
 
Recording Animal Motor Behavior before and after DA Agonism 
 
An animal protocol guiding this work was approved by the University of 
Tennessee Health Science Center's Laboratory Animal Care Unit's Institutional Animal 
Care and Use Committee. Male Pitx3Null and WT mice aged 6 (+/-4) months were used 
for all experiments as follows. A mouse was recorded beginning ~ 1 week after 
microdrive implantation while tethered to a commutator via lightweight headstage cable 
(Omniplex, Plexon Inc., Dallas, TX). A baseline saline injection was given 10 min after 
recording began, and the animal was allowed to explore the ~8”x8”x8” cage (having no 
top, see Figure 8). After ~ 80 min. had passed from recording start, l-DOPA (25 mg/kg 
with 5 mg/kg benserazide) or D1 agonist (1.0 mg/kg SKF 81297, higher doses tended to 
lead to epilepsy in Pitx3Null animals; this dose also minimized WT responses without 
going below our known significant responses in Pitx3Null mice from Li & Zhou, 2013) 
was injected, and 160 (l-DOPA) or 80 (D1 agonist) min were allowed to pass before the 
recording ended or another drug was delivered (for qualitative comparison). Doses for 
quantitative comparisons were given ~24 h apart from each other. 
 
 
Electrophysiological Recordings 
 
On each animal a microdrive array containing 16 Au-plated-nichrome electrode 
channels in various combinations of poly-trodal configuration (bundles consisting of 
between 4 and 8 wires) was implanted. A stimulating electrode was included in some 
microdrives for stimulating antidromic spikes from the substantia nigra reticulata in order 
to identify striatonigral SPNs. Surgery was performed under ketamine-xylazine (90 
mg./kg. ketamine +10 mg./kg. xylazine in 1uL/g. .9% saline) anesthesia following 
standard procedures for rodent survival surgery (e.g. Richter et al, 2013). 
 
Raw recordings were band-pass filtered in the acquisition software (Omniplex 
Server, Plexon Inc., Dallas, TX) 100 - 8000 Hz. Units were detected and classified by 
their thresheld energy. Initially, putatively single unit clusters in various 3-dimensional 
metric spaces (e.g. using principal components, non-linear energy, time slices, etc. in 
Offline Sorter v3, Plexon Inc. Dallas, TX) were used to make unit templates, which were 
used as the basis for template-based sorting of remaining waveforms. Previously 
published criteria utilizing auto-correlations (not shown), inter-spike interval histograms, 
and spike waveshape were used for classifying units as SPN, or non-SPN (e.g. Mallet et 
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Figure 8. The Open Field Cage.Placed in front of a mirror inside a hollowed out 
filing cabinet, an 8”x8”x8” clear plastic cage having no top served as the mouse's open 
field. A cap of water is in the middle of the cage at the moment, although this was not 
routine. See text for details.  
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al, 2005, Schmitzer-Torbert and Redish, 2008). (Figure 9) All publication quality SPNs 
were characterized by ellipsoids of 1.96 standard deviations (as set in Offline Sorter) 
being out of contact with the nearest unit ellipsoids in a choice feature space (usually 
principle component space), having <0.1% of spikes violating a refractory period of 2.0 
msec, and >90% of spikes recovered (inferred by comparing the distribution of valley 
values to an expected gaussian distribution; data not shown). An exemplary recording, 
units, and ID metrics are shown in Figures 10-13. 
 
 
Antidromic Identification of Single Units 
 
In order to ascertain the role of D1-SPNs here, they were putatively 
electrophysiologically identified in the hopes of finding them among those increasing 
activity (consistent with the canonical rate model) and to look for any evidence that their 
activity opposed expectations. Striatonigral (D1 receptor-expressing) SPN identification 
was accomplished using antidromic spikes elicited by stimulating the substantia nigra 
(Ryan et al, 1989); because this technique likely produces false negatives (Mallet et al, 
2006) and because irresolvable cells responding to stimulation may confound 
interpretation, commentary concerning the subset of identified cells is restricted to those 
that responded unambiguously (better isolated than most and with minimal overlap from 
co-responding units) to nigral stimulation and is not necessarily representative of the 
entire population of striatonigral SPNs. Serendipitously, we also found evidence of 
antidromic spikes in fibers of passage (detailed in the second portion of this study).  
 
A parallel bipolar electrode having uninsulated tips 0.10 mm long and spaced 0.25 
mm (WEST30.1A10; Microprobes, Gaithersburg, MD) was included in some 
microdrives for implantation into the SNr, at 3.25 mm. posterior to bregma, 1.28 and 1.53 
mm lateral to midline, and 4.25 mm below dura. Stimulation of all nearby excitable 
neuronal elements using current intensities varying between 100-500 uA elicited 
antidromic spikes. Stimulation patterns consisted of either x number of biphasic pulses 
0.5 msec in total duration having varying interstimulus intervals as noted, or of x number 
of monophasic pulses of 0.05 msec total duration having varying interstimulus intervals, 
as noted; trains were applied every 20 seconds using a stimulus isolator (A-365; WPI, 
Sarasota, FL) triggered by a Master 8 (A.M.P.I., Jerusalem, Israel). These responses were 
recorded in the striatum and identified as either potential direct pathway SPNs (based on 
SPN metrics and saved for the first portion of the study) or possible fibers of passage 
(and saved for the latter portion of the study) if the antidromic response fit the following 
criteria: lower response latency (putative fibers <2 msec., SPNs ~6-13 msec.) time-locked 
to the stimulation, and an all-or-none quality at peri-threshold stimulation currents. For 
all SPNs and three of the four fiber-like units of interest reported responding, further 
evidence was collected: an absolute refractory period <2 msec, and in collisions with 
spontaneous orthodromic spikes. A schematic and exemplary responses to stimuli are 
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Figure 9. Raw Data and Isolated Units.Upper panel – raw data (vertical sub-panels 
represent electrodes 1-4 from top to bottom)Lower left panels – waveforms from a 
putative fiber (middle) and SPN (bottom) that responded to stimulation with antidromic 
spikes. Lower right panels – ISI histograms from respective units to the left.Narrow 
waveform (full-width at half-max <0.2 msec) and many fewer pause durations >1 sec 
would normally preclude this neuron from being considered projection type, (i.e. SPN, 
the only units that project outside the striatum), and most would consider its mean rate 
(~5 Hz) to be fast enough firing to qualify it as a FSI. The lower unit is putatively 
identified as SPN due to the waveshape (>0.2 msec, much longer than putative FFNs) 
and the log-ISI histogram having an approximately bimodal ISI distribution with several 
pauses longer than one second and as long as hundreds of seconds (as distinct from 
TANs, which otherwise share waveform length and but have a reliably leptokurtic 
unimodal log ISI distribution). 
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Figure 10. Exemplary Dorsal WT Data under l-DOPA.  
Upper right: lesion in non-/dorsal striatum. Upper left: raw data from a recording in this 
locale. Middle right: average (+/- std) of one isolated unit’s wavefrom from the 
recording.. Middle left: spike rate of this unit over experiment time (1 sec. bins). Lower 
right: autocorrelogram of this unit’s spike activity (5 msec bins). Lower left: interspike 
interval (ISI) histogram of this unit’s spike activity (log-plot, 10 non-linear bins per 
decade)  
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Figure 11. Exemplary Non-Dorsal WT Data under l-DOPA.  
Upper right: lesion in non-/dorsal striatum. Upper left: raw data from a recording in this 
locale. Middle right: average (+/- std) of one isolated unit’s wavefrom from the 
recording. Middle left: spike rate of this unit over experiment time (1 sec. bins). Lower 
right: autocorrelogram of this unit’s spike activity (5 msec bins). Lower left: interspike 
interval (ISI) histogram of this unit’s spike activity (log-plot, 10 non-linear bins per 
decade) 
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Figure 12. Exemplary Non-Dorsal Pitx3Null Data under l-DOPA.  
Upper right: lesion in non-/dorsal striatum. Upper left: raw data from a recording in this 
locale. Middle right: average (+/- std) of one isolated unit’s wavefrom from the 
recording . Middle left: spike rate of this unit over experiment time (1 sec. bins). Lower 
right: autocorrelogram of this unit’s spike activity (5 msec bins). Lower left: interspike 
interval (ISI) histogram of this unit’s spike activity (log-plot, 10 non-linear bins per 
decade) 
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Figure 13. Exemplary Dorsal Pitx3Null Data under D1 Agonist.  
Upper right: lesion in non-/dorsal striatum. Upper left: raw data from a recording in this 
locale. Middle right: average (+/- std) of one isolated unit’s wavefrom from the 
recording . Middle left: spike rate of this unit over experiment time (1 sec. bins). Lower 
right: autocorrelogram of this unit’s spike activity (5 msec bins). Lower left: interspike 
interval (ISI) histogram of this unit’s spike activity (log-plot, 10 non-linear bins per 
decade) 
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shown in Figure 14 and throughout the results. Reduction in the variability of response 
latency shortly following (less than hundreds of msec) any spikes (previous antidromic 
spikes in this case) may also be seen in some cases (Swadlow et al, 1978; Ryan et 
al ,1989). SPNs were considered unidentified if any criterion was not met; exemplary 
collisions are shown in Figure 15. Corecorded fiber-like units having similar 
characteristics but not responding to stimuli are also presented as unidentified non-SPN 
units. 
 
 
A Note on Technical Differences Between the Two Studies 
 
For the latter study on putative fibers of passage two mice were used, both male 
and aged 4-6 months: one C57bl/6 and one Pitx3Null. On each animal a microdrive array 
was implanted aiming octrodes at the dorsolateral striatum (AP +.4, ML 2.0 - 2.5, DV 1.6 
- 2.0 mm. below dura). All other parameters were the same as the first study minus the 
dosing of drugs and subsequent comparisons. 
 
 
Statistical Considerations 
 
Each SPN's baseline was calculated as the mean number of spikes per second by 
counting all spikes recorded during the pre-drug period (defined from the saline injection 
+35 seconds through the pre-drug-injection period until 35 seconds before drug injection) 
and dividing by the duration of said period. Each SPN's response polarity was calculated 
as the sign of the response intensity before taking it's absolute value (thus, a negative 
indicated a decrease in mean spiking and a positive indicated increase.) Each SPN's 
response intensity to a drug injection was calculated as the absolute value of the 
difference of the base10 logarithm of pre-injection (i.e. baseline) from post-injection (i.e., 
response) mean rates, i.e. log10(post mean rate) – log10(premean rate) = log10(post mean 
rate / premean rate). The threshold depth for considering a unit as dorsal or non-dorsal 
was 2.25 mm below dura. 
 
Various metrics including mean baseline rate, response polarity (i.e., increasing or 
decreasing mean rate), and log (post/pre mean rate) from every recorded SPN were 
calculated in and exported from Matlab (The Mathworks, Inc, Natick, MA) to an *.xls 
file. SAS software, version 9.4 (SAS Institute Inc., Cary, NC, USA ), running (as with all 
other software) under Windows 7 Enterprise, was used to import this *.xls file and to 
perform subsequent statistical modeling.  
 
Given a potential (and later verified –data not shown) correlation among SPN 
metrics within animal, a mixed modeling approach was taken using the GLIMMIX 
procedure in SAS. Thus, mean log-transformed baseline rates (taking each animal's 
largest sample of neurons between one or the other dataset, l-DOPA or D1 agonist), 
response polarity (per dataset) and log10 mean rate change (per dataset) were modeled 
separately from each other. Model building started with the full 3-way interaction (i.e.,  
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Figure 14. Antidromic Spike Technical Theory.  
Left panels from top to bottom – Mouse parasagittal brain sections and overlaid traces of 
major structures show that because cortical axons pass through the cerebral peduncle (cp) 
and terminate after the SNr, their axons may transmit an antidromic spike (2) past a 
striatal recording electrode (1) to the cortical soma during SNr (and thus potentially cp) 
stimulation; this response would be expected to happen faster than in SPNs due to 
saltatory conduction and larger axon diameter, but pass to the SNr directly. Striatopallidal 
neurons would not be expected to respond to stimulation at all due to their field of 
projection stopping short of the SNr. Upper and Middle right panels – Coronal mouse 
brain sections highlight representative SNr stimulation (1) and striatal recording (2) sites. 
Lower right panel – Representative short-latency (-3.5 - +11.5 msec) responses to nigral 
stimulation (note representative all-or-none quality of earliest response expected from 
antidromic spikes at peri-threshold stimulation current). 
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Figure 15. Representative Antidromic Identification Criteria and Collisions.  
Upper left - Nigral stimuli 2.0 msec. apart elicit two corresponding spike responses at the 
recorded SPN soma Lower left - Same using 0.5 msec interstimulus interval in order to 
show single response Upper right - Collisions from the same unit’s antidromic spikes 
with its spontaneous orthodromic spikes are evident in the first first and third stimuli and 
not in those remaining during which no spontaneous orthodromic spikes occurred (note 
consistent latency of antidromic responses) Lower right – The mean waveform +/- 
standard deviation of the responding SPN is shown. 
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baseline*genotype*depth + all 2-way interactions and main effects), which if 
insignificant was followed by the model having the 3-way without the insignificant 2-
way interactions. If the 3-way interaction was not significant, then all two way 
interactions were included and modeling proceeded by removing highest order most 
insignificant interactions before moving to the final modeling phase. Since responses 
from most animals came from only one depth out of two possible, then there was little 
overlap within animal over depth coverage, i.e., only 3 of 19 animals yielded responses 
from both depths. Thus, degrees of freedom for F-tests and post-hoc analyses were 
calculated using SAS's updated Kenward-Roger's adjustment called “kr2” in the “ddfm” 
option of the “model” statement. Baselines, l-DOPA response polarities (as a binary 
response) and intensities (as a continuous response), and D1 agonist response polarities 
(as a binary response) and intensities (as a continuous response) were modeled separately 
using the above approach. 
 
Only three post-hoc comparisons were planned: the effect of a unit change in 
baseline rate on dorsal Pitx3Null drug responses, the effect of genotype on dorsal 
responses (i.e. Pitx3Null dorsal v. WT dorsal) and the effect of depth within Pitx3Null 
animals (i.e. Pitx3Null dorsal v. Pitx3Null non-dorsal responses). Post-hoc comparison p-
values for differences between specific subgroups of the interactions were corrected with 
a stepdown Sidak adjustment (a.k.a. Holm-Sidak). We report adjusted, unadjusted and 
Type III p-values as noted below. 
 
In order to mitigate complications involved in reporting the model results, the 
reader may find it useful to recall the reference and non-reference groups categorized for 
each factor. “WT” and “non-dorsal” were taken as reference classes; however, for 
baseline spiking (which is a continuous variable), one log10 unit higher baseline value is 
taken as the reference value in order to showcase enhancements in the responses that are 
due to low baselines since correlations with baseline were negative. This allows 
comparisons of the average non-reference SPN as the group with enhanced response 
having a baseline one tenth of the average reference (i.e. a log10 unit higher) (or yielding 
a positive odds ratio –O.R.– by being the numerator). This becomes especially useful 
when interpreting O.R.s for interactions, for which the factor precedes the ratio; e.g., 
“baseline O.R. = 1.23*” defines an Odds Ratio in which the Odds estimate for the 
average SPN having a baseline rate one tenth that of the reference group (i.e. non-
reference category making up the numerator) is 1.23 times higher than the Odds estimate 
for the reference group, which is the average SPN having a baseline ten times the non-
reference (i.e. reference category making up the denominator). (Odds represent the 
probability of an increase over that of a decrease and are only explicit in the intercept, 
i.e., are implicit or factor\subgroup-dependent in O.R.s.) Appending a certain subgroup to 
the O.R. name (e.g., Pitx3Null depth O.R.) specifies to which subgroup an analysis was 
restricted. 
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CHAPTER 4.    RESULTS 
 
 
Results for DA Agonism in DA-Deficient SPNs  
 
Databases are tabulated below (Tables 1 and 2) for the three experiments: 
baseline comparisons, responses under l-DOPA and responses under SKF 81297. 
 
 
Basal SPN mean firing in WT and DA-deficient Pitx3Null mice 
 
In order to ascertain an effect of Pitx3Null genotype on baseline SPN spiking, 
baseline rates were compared between genotypes and depths. Since the distribution of 
baseline rates spanned >3 orders of magnitude (0.00097 – 5.94 Hz; median 0.185 Hz, 
Table 3), log10(baseline) was used. No significant baseline rate differences between 
factors were found for this dataset. (Figure 16) Given no spiking distinction for DA-
deficient SPNs overall, we explored their responses to DA agonism using l-DOPA and 
D1 agonist.  
 
 
Response polarity differences among WT and DA-deficient Pitx3Null mice 
 
With respect to the canonical rate model, an overall spiking increase or decrease 
in response to DA agonists has been used as a metric for subtype identification of SPNs 
(e.g. Liang et al., 2008, Singh et al., 2016). Having noticed both response polarities after 
the putatively selective D1-type receptor agonist SKF 81297 (Figure 17), we explored 
both datasets separately for differences in response polarity ratios, i.e. odds of increases 
compared to decreases dependent on possibly full interactions of our 3 factors of interest: 
log10(mean baseline rate), depth and genotype. 
 
The baselines dataset includes a total of 198 SPNs from 19 animals split into four 
groups determined by genotype and depth interaction, i.e. WT non-dorsal and dorsal as 
well as Pitx3Null non-dorsal and dorsal. Seven animals contribute to the dorsal datasets 
for each genotype (57 SPNs from Pitx3Null animals and 46 from WT), whereas non-
dorsal data comes from 3 Pitx3Null and 6 WT animals (67 and 27 SPNs, respectively). 
During experiments, we observed firing rate changes that were not immediately obvious 
as to whether or not cells increased or decreased activity (Figures 18-21), especially 
since SPNs can go many minutes without spiking. Thus we assessed the polarity of any 
change in firing as an increase, –i.e. positive– if the result of subtracting the log10(mean 
baseline) from the log10(mean response) was positive, and negative otherwise. No 
allowance was made for SPNs having “no change” in activity for two main reasons; this 
would require testing increases in rate separately from decreases (or removing 
insignificantly changing SPNs from the dataset, requiring post-hoc classification that 
nullifies the generality of the model); and there is no particularly well-suited statistical   
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Table 1. Datasets Used. 
 
 Pitx3Null SPNs WT SPNs 
Baselines (from subset of non-
overlapping drug recordings) 
  
dorsal 57 cells in 7 animals 46 cells in 7 animals 
non-dorsal 67 cells in 3 animals 27 cells in 6 animals 
l-DOPA    
dorsal 48 cells in 7 animals 37 cells in 6 animals 
non-dorsal 55 cells in 3 animals 25 cells in 4 animals 
SKF 81297    
dorsal 32 cells in 4 animals 33 cells in 6 animals 
non-dorsal 59 cells in 2 animals 29 cells in 7 animals 
 
 
 
 
Table 2. Antidromically Identified Cell Subset. 
 
 Pitx3Null SPNs 
(antidromically 
identified) 
WT SPNs 
(antidromically 
identified) 
Baselines (from subset of non-
overlapping drug recordings) 
  
dorsal 6 cells in 3 animals 6 cells in 3 animals 
non-dorsal (N\A) (N\A) 
l-DOPA    
dorsal 6 cells in 3 animals 5 cells in 2 animals 
non-dorsal (N\A) 2 cells in 1 animal 
SKF 81297    
dorsal 3 cells in 1 animals 8 cells in 3 animals 
non-dorsal (N\A) 2 cells in 1 animal 
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Table 3.  Baselines between Genotype and Depth. 
 
Genotype Depth N Obs Minimum 
Lower 
Quartile 
Median 
Upper 
Quartile 
Maximum 
Pitx dorsal 57   0.00100  0.04337 0.43982 0.52062 4.79883 
Pitx 
non-
dorsal 
67   0.00336  0.08496 0.16785 0.67718 5.21594 
WT dorsal 46   0.00097  0.07507 0.28397  0.81032 5.94051 
WT 
non-
dorsal 
27   0.01291   0.03672 0.12216 0.28427 3.66251 
 
 
 
 
 
 
Figure 16. Modelled Mean Baselines +/- Standard Errors for Each Group.  
Linear y-scale reflects Log10(baselineModeled means +\-respective standard errors for 
each group. 
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Figure 17. Unexpected Responses to Selective D1 Agonism.  
Upper panels – Exemplary dorsal Pitx3Null data under D1 agonism. Upper right sub-
panel: lesion in dorsal striatum. Upper left sub-panel: raw data from a recording in this 
locale. Middle right sub-panel: average (+/- std) of one isolated unit’s waveform from the 
recording Middle left sub-panel: spike rate of this unit over experiment time (1 sec. bins). 
Lower right sub-panel: autocorrelogram of this unit’s spike activity (5 msec bins). Lower 
left sub-panel: interspike interval (ISI) histogram of this unit’s spike activity (log-plot, 10 
bins per decade) Lower panels – same as above but for WT and non-dorsal. 
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Figure 18. Exemplary Dorsal Pitx3Null Responses to l-DOPA.  
Upper right – Injections shown using each cell’s maximal duration and rate for x and y-
axes, respectively. Lower left – Same injections shown uniformly at 1800 sec by clipping 
recording starts and ends; “B” here is upper left of upper right panel; panels are read 
across before down.)  
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Figure 19. Exemplary Non-Dorsal Pitx3Null Responses to l-DOPA.  
Upper right – Injections shown using each cell’s maximal duration and rate for x and y-
axes, respectively. Lower left – Same injections shown uniformly at 1800 sec by clipping 
recording starts and ends; “B” here is upper left of upper right panel; panels are read 
across before down.)  
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Figure 20. Exemplary Dorsal WT Responses to D1 Ag.  
Upper right – Injections shown using each cell’s maximal duration and rate for x and y-
axes, respectively. Lower left – Same injections shown uniformly at 1800 sec by clipping 
recording starts and ends; “B” here is upper left of upper right panel; panels are read 
across before down.)  
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Figure 21. Exemplary Non-Dorsal WT Responses to l-DOPA.  
Upper right – Injections shown using each cell’s maximal duration and rate for x and y-
axes, respectively. Lower left – Same injections shown uniformly at 1800 sec by clipping 
recording starts and ends; “B” here is upper left of upper right panel; panels are read 
across before down.)  
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test for such sporadic spiking as SPNs exhibit. The usual t-test for firing rate differences 
presumes a normal distribution of spikes per time binned in x second increments, the 
standard deviation of which is vulnerable to bias by varying the duration of each time bin, 
x. Exploration of the effect of varying time bin duration left us with no obvious way to 
decide on an appropriate increment; thus a t-test procedure on its face did not seem to 
match SPN spiking patterns and lends itself to bias for which we could not account in 
order to resolve statistical from biological significance. 
 
 
l-DOPA response polarities 
 
Modeling the odds of a SPN increasing rate in response to l-DOPA thus revealed 
a significant effect of baseline rate, which interacted significantly with depth (Table 4), 
but there was no significant effect of genotype. According to model estimates, upon 
injection of l-DOPA, the odds of a positive response polarity were significantly lower 
with higher baselines, i.e., there was a significant negative correlation between baseline 
and the odds of a spiking-increase in response to l-DOPA; specifically, according to the 
resulting baseline O.R., the average SPN having a tenth the baseline spiking of another 
had 3.261 times higher odds (Type III p < 0.0002) of increasing spiking. 
 
This significant negative correlation was significantly exaggerated in the dorsal 
striatum compared to non-dorsal regardless of genotype. The baseline O.R. specifically 
for the average dorsal SPN having a tenth the baseline of another was 7.40:1 (adjusted p 
= 0.0010). while that for non-dorsal was 1.44:1 (untested). These O.R.s were 
significantly different (depth-baseline O.R. = 5.14*, Type III p = 0.0082), i.e., SPNs in 
dorsal striata had 7.4 times higher odds of increasing spiking, which odds were 5.10 
(7.40/1.44 = 5.10) times higher than non-dorsal odds of increasing spiking. 
 
 
D1 agonist ersponse polarities 
 
Upon injection of D1 agonist, the odds of a positive rate response polarity (i.e. a 
spiking increase) were significantly different in terms of a genotype-depth interaction and 
a 3-way interaction that included baseline in which (as with l-DOPA) lower baselines 
predicted a greater chance of an increasing spike rate in response to drug, i.e. a negative 
correlation with baseline spiking.  
 
Post-hoc comparisons of classes within the genotype-depth interaction (i.e. having 
set log10(baseline) to various levels (spanning a half log unit on either side of the average 
baseline, ~ -1.32 – -0.32) in order to account for differences it made since it was involved 
in a significant 3-way interaction) revealed somewhat lower odds for Pitx3Null dorsal 
SPNs having baselines higher than average to increase activity than WT dorsal SPNs. 
The other planned comparison was between depths in Pitx3Null mice, which gave p > 0.3 
for every baseline tested. Although not strictly tested during multiple comparisons, a 
depth gradient in WT was more evident at higher baselines than average (data not 
shown).  
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Table 4. Overall Significant Results and Post-Hoc Comparisons for Both Drug 
Response Datasets. 
 
 l-DOPA 
   polarity           intensity 
SKF 81297 
   polarity           intensity 
Genotype -0.69x +0.43* -0.77 +0.025 
Depth -1.36x +0.07 +1.16 -0.055 
Genotype * Depth N\A +0.27 -4.05* N\A 
log10(baseline) -3.3x* -0.27* +0.51 -0.35* 
log10(baseline) * Depth -7.4x* N\A N\A N\A 
3-way interaction N\A -0.37* 32x* 0.27* 
Planned and unplanned 
comparisons 
    
WT depth interaction N\A Untested +24.1x** N\A 
log10(baseline) correlation 
with Pitx3Null dorsal 
intensities 
N\A -0.23 -4.7x* -0.51* 
Difference in 
log10(baseline) correlation 
made by genotype  
N\A +0.11 -6.9x -0.35* 
Difference in 
log10(baseline) correlation 
made by depth  
N\A +0.15 -6.6x* -0.10 
 
(* = p <0.05 adj.) 
(** = p <0.05 unadjusted) 
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Planned post-hoc testing of estimated differences between 3-way subgroups 
revealed that Pitx3Null dorsal SPNs showed a significant effect of baseline changes 
(Pitx3Null-dorsal-baseline O.R. = 4.69*, adjusted p < 0.0471, i.e. a unit decrease in these 
particular SPNs' baselines predicted significantly higher odds of a rate increase than 
decrease in response to D1agonism); furthermore, this baseline effect was significantly 
exaggerated in the Pitx3Null dorsal location compared to non-dorsal SPNs (i.e. 
Pitx3Null-depth-baseline O.R. = 6.56:1, adjusted p < 0.0464, i.e. a stronger negative 
association with baseline dorsally).  
 
Comparing Pitx3Null dorsal correlation with baseline to WT dorsal correlation with 
baseline indicated that genotype did not significantly alter dorsal-baseline O.R.s 
(genotype-dorsal-baseline O.R. = 6.874, adjusted p = 0.0825). However, accounting for 
the difference made by depth to the negative baseline correlation, then comparing 
genotypes (i.e. Pitx3Null depth effect on baseline correlation normalized to the same in 
WT) yielded an estimated genotype-depth-baseline O.R. = 32.63* (TYPE III test p = 
0.013), i.e. the depth effect on the negative correlation with baseline was exaggerated 
significantly in the Pitx3Null DA gradient compared to WT, which has no such DA 
gradient (Figure 22). 
 
Overall then, in terms of the 3-way interaction, the DA gradient in Pitx3Null 
animals was “top-heavy” (i.e. more negative baseline correlation for dorsal SPNs) in 
stark contrast to the “bottom-heavier” depth gradient expectation set by WT. Although 
statistical significance was not tested for (let alone reached) in most of these subgroups, 
this overall pattern of “different differences” made to the baseline correlations varying by 
depth and genotype is nonetheless significant as indicated by the Type III p for 3-way 
interaction. Closer inspection of otherwise insignificant patterns in individual group 
estimates (at representative baselines, i.e. +\- a half log unit around the log mean, ~ -0.8 
for both genotypes) suggested the tendency of even high baseline dorsal WT SPNs to 
increase spiking. This made for a much weaker baseline correlation whereas non-dorsal 
WT SPNs seemed not to correlate so weakly. Comparing this depth effect in WT (WT-
depth-baseline O.R. = 0.201x, unadjusted p = 0.166) to that in Pitx3Null animals (4.69x) 
revealed a significant inversion (genotype-depth-baseline O.R. = 32.63x) whereby 
Pitx3Null dorsal SPNs in particular maintained a significantly negative baseline 
correlation that was significantly stronger than that in non-dorsal, and significantly more 
so (dorsal stronger than non-dorsal) than WT; thus odds were greater for SPNs having 
lower rates to increase spiking (and higher for SPNs having higher rates to decrease) in 
dorsal Pitx3Null striatum than expected given the WT change in correlation with depth 
(and given the canonical rate model). 
 
 
Response intensity differences among WT and DA-deficient Pitx3Null mice 
 
In order to test the hypothesis that the DA denervation in Pitx3Null dorsal SPNs 
causes exaggerated spiking responses to DA agonism relative to dorsal WT and non-
dorsal Pitx3Null SPNs (having greater DA innervation), we recorded SPN responses to l-
DOPA (25mg/kg with 5 mg/kg benserazide) or SKF 81297 (1 mg/kg) injections  
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Figure 22. Response Polarity vs. Log Baseline.  
The probabilities associated with these increasing relative to non-increasing responses 
were modeled and fitted separately for each class. Dorsal data is lighter than non-dorsal  
(in between is the mean for both, I.e. genotype mean); WT are cool colors (blue shades), 
Pitx3Null are warm colors (red shades).1= increase, 0=decrease. 
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following baseline recordings. SPNs responded with varied intensities: from low (< 0.01 
Hz) baseline rates having high rate responses (~ 1 Hz) to vice versa and all combinations 
thereof. These responses were clear on both drugs in both depths from Pitx3Null animals, 
although generally appeared to be less intense in WT (Figures 18-21).  
 
The absolute magnitude of the response intensity was taken so as to avoid using 
the overall mean of responses flanking (and thus tending toward) zero; also subsetting the 
responses into in-/decreasing would risk the generality of the model via post-hoc 
classification. Again, because the distribution of differences between responses and 
baselines spanned a similar range as the baselines (range = 0.00056 – 8.3 Hz, i.e. ~4 
orders of magnitude, Figure 23; data shown explicitly only for D1 agonist, but l-DOPA 
responses were similar), the difference between log10(response) and log10(baseline) –to 
which we refer as the intensity– was used for the dependent variable in the model, We 
modelled the intensity as a function of our three factors of interest: log10(baseline), depth, 
and genotype, plus interactions. 
 
 
l-DOPA response intensities 
 
Upon injection of l-DOPA, both response polarities –i.e. absolute values of both 
increasing and decreasing log10(post/pre rate)– were more intense: 0.426 log10 units 
according to modelled mean difference at log10(baseline) = 0 (Type III p = 0.0354) in 
Pitx3Null animals averaged across depth (a linear factor of about 2.7x more intense). 
They were also more intense the lower the baseline: (0.269 log10 units per unit decrease 
in log10(baseline) averaged across all classes. In linear units this is a factor of about 1.9x 
more intense. 
 
Planned post-hoc tests for the significant 3-way interaction indicated that the 
slope of baseline in Pitx3Null dorsal striatum was not significantly non-zero after Holm-
Sidak correction (0.233, adjusted p = 0.0635), was not significantly stronger than WT 
dorsal slope due to baseline (difference = -0.101, adjusted p ~ 0.5), and was not 
significantly stronger than Pitx3Null non-dorsal striatal SPNs (-0.155, adjusted p ~ 0.5). 
Exploring the remaining subgroups revealed that the slope of baseline in WT dorsal 
striata was likely non-zero (0.335 log units per log unit decrease in baseline, unadjusted p 
< .0001; this corresponds to a linear factor of about 2.2x more intense at a baseline 10% 
that of reference) and possibly higher than non-dorsal WT SPNs (0.213 log units, 1.63x 
linear factor unadjusted p < 0.0382). However, the difference made by depth to the 
baseline's effect (on response intensity) in Pitx3Null animals normalized to the same in 
WT was weaker within the Pitx3Null DA gradient: an estimated -0.368 log10 units per 
log10 unit baseline decrease (TYPE III test p = 0.0477), i.e. ~43% that of WT.  
 
These 3-way interaction results overall indicate an inversion of a slight depth 
effect in WT on the negative correlation of baseline with intensity; whereas Pitx3Null 
dorsal SPN baseline correlations compared to those of non-dorsal Pitx3Null SPNs were 
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Figure 23. Mean Post-Drug Responses Are as Log-Distributed as the Baselines.  
Upper left – Mean baseline rates before D1 agonist (~70% of all baseline data –partially 
overlapping approximately with that of l-DOPA–, i.e. majority of baseline data and 
representative of entire dataset) are shown with respect to animal ID. Upper right – 
response intensities to D1 agonism vs. animal ID. Middle left – Mean post-D1 agonist 
rate vs. mean baseline rate (log-scale) for WT dorsal cells. Middle right – as above for 
WT non-dorsal cells. Lower left – as above for Pitx3Null dorsal cells. Lower right – as 
above for Pitx3Null dorsal cells  
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not significantly different, this difference was nonetheless significantly (0.368 log10 units, 
a linear factor of ~0.43x) less than WT, where dorsal baseline correlations were likely the 
most significant and the depth effect on these correlations may or may not have been. 
 
 
D1 agonist response intensities 
 
Upon injection of D1 agonist, both response polarities (i.e. absolute values of both 
increases and decreases in spiking) were significantly different in a 3-way interaction of 
baseline rate, genotype and depth. Direct post-hoc pairwise difference estimates revealed 
that the significant negative correlation of baseline rate with response intensity (0.345 
log10 units of intensity per log10 unit decrease in baseline averaged across all 4 classes, p 
< 0.0001, corresponding to ~2.2-fold increase at 10% baseline) was significantly stronger 
in Pitx3Null dorsal striatum (0.507, adjusted p < 0.0001, a linear factor of ~3.2x stronger 
per 10% baseline) than WT dorsal (0.153): difference = 0.354 log units, adjusted p = 
0.0083, a linear factor of 2.26x in Pitx3Null). Pitx3Null dorsal striatum did not differ 
significantly from Pitx3Null non-dorsal striatum (difference = 0.103, adjusted p ~ 0.4). 
Although the depth effect on baseline correlations was inverted between genotypes, this 
effect was not significant; the Type III p-value represents the difference between 
genotype dorsal baseline correlations, i.e., a significant difference between at least two of 
the three subgroups (having already accounted for the doubly referential group, WT non-
dorsal.) 
 
 
Antidromically identified SPNs are deficient in baseline spiking and respond 
strongly to DA agonism 
 
Having been unable to use D1 agonism to differentiate satisfactorily between 
striatonigral and striatopallidal SPNs, and in order to potentially uncover a role of D1-
SPNs for the response intensity, they were putatively identified electrophysiologically in 
the hopes of finding them among those increasing activity (consistent with the canonical 
rate model) and to look for any evidence that their activity opposed expectations. 
Striatonigral (D1 receptor-expressing) SPN identification was accomplished using 
antidromic spikes elicited by substantia nigra stimulation (Ryan et al, 1989).  
 
(Because this technique likely produces false negatives (Mallet et al, 2006) and 
because irresolvable cells responding to stimulation may confound interpretation, 
commentary concerning the subset of identified cells is restricted to those that responded 
unambiguously – i.e., better isolated than most and with minimal overlap from co-
responding units– to nigral stimulation and is not necessarily representative of the entire 
population of striatonigral SPNs.) Antidromically identified SPN baselines (all dorsal) 
include a total of 6 SPNs from 3 Pitx3Null animals and 8 SPNs from 3 WT animals. Non-
parametric statistics for these data are shown in Table 5. The antidromically identified  
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Table 5. Antidromically Identified Cell Baselines Between Genotype and 
Depth. 
 
Genotype Depth 
N 
Obs 
Minimum 
Lower 
Quartile 
Median 
Upper 
Quartile 
Maximum 
Pitx3Null dorsal 6 0.01976 0.02027 0.02640 0.08764 0.08764 
WT dorsal 8 0.01183 0.20093 0.31922 0.46390 5.94051 
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cell baselines were found to be significantly lower (on average -0.937 log units +\- std err 
0.297, p < 0.05) in Pitx3Null animals than WT. In linear units this corresponds to Pitx 
(10-1.486 +/- 0.111=) 0.0327 Hz +0.0095/-0.0074 and WT (10-0.549 +/- 0.276=) 0.282 Hz +0.251/-
0.132 yielding a log difference (aka linear factor) of between 5.83-22.9% of WT centered 
on 11.6% (i.e. 10-0.937 +/- 0.297). 
 
Furthermore, no identified Pitx3Null cells decreased activity in response to either 
drug; this made odds infinite with respect to WT decreases and thus precluded polarity 
analyses. Figure 24. 
 
Finally, the response intensities were all higher for dorsal Pitx3Null cells than 
WT. However, given the small sample size in the antidromically identified subset, t-tests 
were used in order to avoid overcomplicating the models for both drugs with 
considerations known to be important in previous models (e.g. intra-animal correlation of 
responses); thus assuming SPN independence allows us to show a preliminarily 
significant difference between genotypes in both datasets best seen in Figure 25 as all 
dorsal Pitx3Null striatonigral cells had higher firing rate response intensities than WT 
striatonigral cells. 
 
 
Results for Fibers of Passage Mistaken as FSIs 
 
During in vivo electrophysiology experiments for a different project (Sagot and 
Zhou, submitted), antidromic identification of direct pathway SPNs yielded occasional 
responses at much shorter latency than expected as seen in Figure 14 (Ryan et al 1986, 
and 1989) and of much shorter waveform duration than expected for SPNs (Mallet, 
2005); compare units in Figure 14. 
 
Four such units were collected and their identification metrics and initial 
responses are presented by row in Figure 26; they demonstrated all-or-none –as opposed 
to graded-- responses to increasing current intensity and consistently followed the 
stimulus at precise latencies 0.5 – 1.63 ms (implying conduction velocities from ~2.7-10 
m/sec). For three of the four units in question, responses to further stimulation patterns 
were collected in order to confirm a refractory period <2.0 msec during which the second 
of two stimuli would not elicit a response. (Figure 26, two right-most columns) (The 
second unit from top was not ignored but accidentally discovered while searching in an 
otherwise uneventful recording, during which stimulations were abandoned due to the 
lack of SPN responses.) 
 
Altogether the pattern of responses for these units suggested an antidromic nature, 
so their recordings were scrutinized for evidence of random collisions, collisions being 
the gold standard identifier of antidromic spikes. Notwithstanding hardware shortcomings 
for trigger latencies (the analog Omniplex system), we occasionally stimulated soon 
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Figure 24. Baseline Data (Least-Squared Means) for Putative D1 Cells.  
Top panel: modeled means +\- respective standard errors for each group bottom panel: 
diffogram showing how far the difference between genotype baselines is from equal (+/- 
standard error). catGT = genotype, logbase = log10(baseline). 
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Figure 
25. Pitx3Null Striatonigral Cells All Hyper-Responsive to Drug Compared to 
WT.  
Response intensity (not absolute value) vs. depth below dura shows the distinctions 
between genotypes for striatonigral SPN responses to both drugs: l-DOPA left, D1 
agonist right. (Note lowest two cells were not included in calculations due to non-dorsal 
depth.) 
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Figure 26. All Responding UnitsLeft-most column - average (+/- std) of waveforms 
isolated from the respective unit’s in question. Middle left column - To the immediate 
right are their respective ISI histograms and rate over time plots. Middle right column – 
Stimulating (train of two stimuli separated by 100 msec) around threshold current yields 
a stimulus artifact without the putative antidromic spike (respective to each unit’s row) in 
the upper panels of this column. In the lower panels, the spike is reliably present after 
increasing the stimulating current.  
Right most column – Upper sub-panels in this column show (in each respective unit’s 
row) nigral stimuli 2.0 - 2.5 msec. apart eliciting two corresponding spike responses 
yielding information regarding the putative antidromic spike’s ability to follow high 
frequency stimulation. Setting the interstimulus interval to <1 msec in order to show only 
single responses to two stimuli (in the lower sub-panels of this column) yields 
information regarding the putative antidromic spike’s refractory period, the presence of 
which excludes the possibility that the spike response is simply part of a stimulation 
artifact. 
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enough after spontaneous spikes to discover such evidence. Collisions are shown in 
Figure 27 (and may be compared to those of a nighboring SPN from Fig. 5, upper unit's 
trace panel). One putative fiber from each animal was occasionally interrupted by what 
appeared to be the same waveform on the same channel, i.e. unexpectedly absent within 
msec's after a similar spike when otherwise present on flanking stimuli, and thus strongly 
reminiscent of an antidromic collision. (Swadlow et al, 1978) 
 
Given the low density of FFNs in the striatum (Luk and Sadikot, 2001, Saka et al, 
2002) and no published knowledge of their tendency to cluster, it is very unexpected to 
find that more than one may be recorded simultaneously, yet exactly such data has been 
reported (Berke, 2008), and indeed all four neurons in this report were accompanied by at 
least one (incompletely recovered) and up to four units (two completely recovered) 
having similarly brief waveforms. (Figures 28) Units lacking waveforms due to 
incomplete recovery (~20-50% false negatives) gave no rate or ISI metrics; however, all 
had the characteristic brief waveform. 
 
All units had a full width at half-max of 0.08-0.18 msec (compared to SPNs 
having 0.15 – 0.35 –Figures 26 and 27, left-most columns and Figure 27 right units, 
SPNs), latency to response of <2 msec, and one unit from each animal was interrupted 
multiple times by spontaneous spikes. Mean rates varied between ~5-17 Hz, and the units 
recorded during quiet rest, and motor activity switched to a bursty mode with long pauses 
reminiscent of reported FSIs (data not shown). (Berke, 2011) 
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Figure 27. All CollisionsLeft unit panels – Topmost panel shows (after establishing 
the latency to response for this spike in the 1.1 – 1.3 msec range) that this first response is 
early enough to be considered spontaneous; no response follows, but the next response is 
appropriately timed. The middle panel shows a spontaneous spike in the second stimulus 
artifact (note exaggerated downward deflection compared to all others during that bout of 
stimulation (exemplified by the first stimulus and thosein the upper panel); even though 
flanking stimuli produced responses, this one did not. The lower panel shows that the 
fourth stimulation (red trace) in a train of four spaced 10 msec apart was preceded (~100 
usec) by a spontaneous (orthodromic) spike; even though flanking stimuli produced 
typical spike responses (first 3 black traces, next train not shown), this one did not.  
Right unit panels - Stimuli artifacts (on all four electrodes, shown vertically) are shown 
flanking the stimulus of interest, on right of upper panel and left of middle panel.  
Multiple stimuli are overlaid and colored in these graphs. Spontaneous spikes from the 
unit of interest precede the stimuli of interest by 0-1 msec; note completely non-
responsive antidromic spikes, putative collisions Lower left panel Traces from 49 stimuli 
at increased current having 100 msec interstimulus interval are overlaid; note unit most 
prominent on third electrode responding to all but two stimuli for each of which a 
spontaneous orthodromic spike apparently precluded the antidromic response; lowest left 
panel shows close-up of stimuli, responses, and putative collisions of interest for the 
same data. 
  
 57 
 
 
 
  
1 2 3 4 5 6 7 51 52 53 54 55 56 57 58
-0.2
-0.1
0.0
0.1
1 2 3 4 5 6 7 51 52 53 54 55 56 57 58
-0.2
-0.1
0.0
0.1
1 2 3 4 5 6 7 51 52 53 54 55 56 57 58
-0.2
-0.1
0.0
0.1
1 2 3 4 5 6 7 51 52 53 54 55 56 57 58
-0.2
-0.1
0.0
0.1
A
m
p
lit
u
d
e
 (
u
V
)
Time (msec)
51 52 53 54 55 56 57 101 102 103 104 105 106 107 108
-0.2
-0.1
0.0
0.1
-0.2
-0.1
0.0
0.1
51 52 53 54 55 56 57 101 102 103 104 105 106 107 108
-0.2
-0.1
0.0
0.1
51 52 53 54 55 56 57 101 102 103 104 105 106 107 108
-0.2
-0.1
0.0
0.1
A
m
p
lit
u
d
e
 (
u
V
)
Time (msec)
5 10
-0.2
-0.1
0.0
0.1
5 10
-0.2
-0.1
0.0
0.1
5 10
-0.2
-0.1
0.0
0.1
5 10
-0.2
-0.1
0.0
0.1
A
m
p
lit
u
d
e
 (
u
V
)
Time (msec)
1
0
0
 u
V
0.5 msec
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.1
0.0
0.10.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.1
0.0
0.10.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.1
0.0
0.10.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.1
0.0
0.1
A
m
p
lit
u
d
e
 (
u
V
)
Time (msec)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
Time (msec) Time (msec)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
-0.15
-0.10
-0.05
0.00
0.05
0.10
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
A
m
p
li
tu
d
e
 (
)u
V
)
Time (msec) Time (msec)
 58 
Figure 28. All Neighboring Units and Two Co-responding SPNsAll units on left 
(and corresponding identification metrics to their immediate right) were recorded 
simultaneously with the respective responding units from Figure 27. (Only the secondunit 
from top of Figure 27 is missing a neighbor due to incomplete recovery; in its place is 
another neighbor from the recording of the 3rd unit from top.) Upper right unit – The 
mean waveform +/- standard deviation of a responding SPN previously recorded is 
shown. ISI histogram of the unit showcasing log normal distribution biased towards) 
longer pauses. In the panel just below a collision between the same unit’s antidromic 
spike in response to the first of four stimuli is not evident (left half), theoretically due to 
the spontaneous spike’s lagging the stimulus by enough time to allow it to pass the 
stimulated portion of axon before an antidromic spike is elicited there; however, the next 
spontaneous spike (right half) precludes the antidromic response in the first of the latter 
four stimuli, theoretically due to collision of the two between the point of recording 
(striatum) and the point of stimulation on the cell’s axon (SNr). 
Lower right unit – The mean waveform +/- standard deviation of a putatively responding, 
co-recorded SPN is shown to left of ISI histogram showcasing log normal distribution 
biased towards longer pauses. In the lowest right panel putative SPNs responded at lower 
thresholds than the unit of interest, as seen most prominently in the first electrode (and 
less so on the fourth). 
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CHAPTER 5.    DISCUSSIONS 
 
 
Discussion for DA Agonism in DA-Deficient SPNs  
 
 
Interpretation within the Canonical Rate Model 
 
In this paper, we demonstrate some long-term effects of DA denervation on SPN 
spiking responses to acute DA agonism: namely, a more drastic rate change in response 
to DA agonism among SPN populations having low baseline spiking and\or located in the 
DA-denervated Pitx3Null dorsal striatum However, this may not be a direct receptor 
influence on spiking since it was found in both dorsal, DA-denervated, and non-dorsal, 
having residual DA, Pitx3Null striatal regions (see further discussion on depth effect). 
We interpret these results on the basis of a modified understanding of the canonical rate 
model allowing for coactivation of striatonigral and striatopallidal cells during behavior 
(e.g. Sippy et al., 2015, Cui et al., 2013) as well as for network effects that may 
overwhelm the effects of DA receptor stimulation on spiking (Ruskin et al., 1999, 
Nambu, 2008, Beeler et al., 2012, Friend & Kravitz, 2014). Given the supersensitized DA 
receptors in DA denervated Pitx3Null dorsal SPNs, we thus expected two primary effects 
of DA agonism: stronger spike-rate intensities in Pitx3Null dorsal than Pitx3Null non-
dorsal SPNs and than WT dorsal SPNs. Our interest in polarity was exploratory inasmuch 
as modifications to the canonical rate model muddy the clarity of its polarity predictions. 
 
In testing for significant group differences and effect sizes in our factors of 
interest, two notable patterns emerged; our predictions were upheld in genotype but not 
depth differences, and baseline spiking had a significant (usually main) effect across the 
entire dataset. Including baseline as a covariate was intended to account for possible floor 
or ceiling effects on rate changes given baseline spiking (e.g. increasing spiking from a 
high baseline is necessarily less of an effect than doing so from a low baseline). 
Furthermore, the higher odds of SPNs increasing activity if they have lower baselines 
combined with the same correlation for intensity implies that increases tended to be more 
intense. This may have implications for DA’s effects on striatal spike coding of 
behaviour. 
 
 
Genotype differences 
 
WT mice placed into an open field and given a behaviorally inert drug, l-DOPA 
(Kim et al., 2000, even after slight DA depletion Costa et al., 2006, although see Huot, 
2015 for a comprehensive review), yield spiking responses used as a control for this 
dataset, reflecting background neuronal processes and/or any changes in open-field 
behavior-related spike-firing as the session runs its course. WT responses to ~2 fold 
extracellular [DA] increase (Abercrombie et al., 1990) are expected to provide the control 
against which presumptively vigorous SPN receptor responses to l-DOPA in Pitx3Null 
yield spiking changes more intense than WT but with a nonetheless similar ratio of 
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putatively D1-based excitatory and D2-based inhibitory responses. Bearing this in mind, 
then interpreting the pattern of baseline correlations (at any level or group) with the 
dependent variables requires knowledge of the “normal”, i.e. WT, dorsal striatal 
correlation of baseline with the dependent variable. Thus expected differences between 
subgroups in the baseline correlations become a central theme in discussing complex 
results.  
 
These expectations change somewhat for D1 agonist, SKF 81297. While the 
authors know of no awake WT data correlating baseline differences with response 
differences, WT locomotive activity is known to increase significantly only at doses 0.5-3 
times that used here (Xu et al., 1997, Usiello et al., 2000, Kim et al., 2000), although 
overall changes in SPN spiking are less straightforward. For example, adding SKF-81297 
to the iontophoretic co-application of glutamate and a D2 agonist in anesthetized mouse 
ventral striatum inhibited the glutamate-induced ~4-5Hz baseline firing rate (relatively 
high considering our dataset range, after log10 transform, of ~ -3 - +1, mean ~ -0.8 ) (Xu 
et al., 1997). In another example, strict application of SKF-81297 in a similar setting for 
dorsal striatum showed no obvious correlation with baseline for polarity or intensity. (Xu 
et al., 2011) Finally, Delfino et al., 2007, found that motor cortical activity was enhanced 
in hemi-lesioned rats having their BOLD response measured, suggesting that motor 
network glutamatergic striatal input plays a larger role in the D1 agonist response than in 
the l-DOPA response for WT. Thus expectations are that high-rate non-dorsal SPNs in 
WT may tend to decrease in rate albeit after drug during locomotor increases, significant 
or not, and any dorsal baseline correlation should be weak, if present at all. 
 
Genotype differences arose at four points in our study; most noticeably in the 
much lower baseline spiking from antidromically identified cells, but also in the l-DOPA 
and D1 agonist intensities as well as D1agonist response polarities. In the l-DOPA dataset 
this manifested as a main effect of genotype as well as a complicated interaction of 
genotype depth and baseline. A similar interaction held in the D1 agonist response 
polarities. Finally, a genotype difference in D1 agonist response intensities was evident in 
the dorsal subgroups. 
 
 
Baselines 
 
The baseline difference in antidromically identified SPN spiking between the two 
genotypes is interpreted as a direct consequence of DA denervation in the Pitx3Null 
animal. The only manipulation in this experimental system is that of lost ventral tier SNc 
DA neurons (and aphakia, which was shown to allow similar rearing behavior in blinded 
versus intact WT controls in Kas et al., 2008); thus, the most parsimonious explanation 
for the baseline spike difference in the brain is the striking DA loss there. 
 
This result is particularly important in light of the baseline behavioral phenotype 
in Pitx3Null mice, These mice have less spontaneous rearing, take longer and more steps 
to traverse the challenging beam, take longer to orient downward in the pole test (Hwang 
et al., 2005), take longer to remove adhesive from snout (Fleming et al., 2013). take less 
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time to fall from the rotarod (Beeler et al., 2009), more time to traverse the balance beam, 
more time to complete the string test, and shred less cotton than WT (Singh et al., 2007). 
These are consistent with canonical rate model and the behavioral effects of deficient DA 
agonism on striatonigral SNr afferents. (Rommelfanger & Wichmann, 2010) 
 
 
l-DOPA responses 
 
l-DOPA's effect on SPNs' spiking was clearly more intense in Pitx3Null than WT 
mice (0.426 log units = 2.67*higher on average), which validates our prediction that 
Pitx3Null SPNs are hyper-responsive to DA agonism compared to WT. Publications 
quantifying spike-rate response intensities to l-DOPA in freely-moving WT mice are not 
known to us, therefore we can only speculate that given their lack of behavioral response, 
their spiking responses would be expected – at the crudest level – to similarly lack 
intensity. 
 
The similar extent to which WT dorsal and Pitx3Null dorsal SPN baselines were 
negatively correlated with spiking change intensities to l-DOPA may be expected if the 
normal WT reduction in motor behavior in the open field over periods longer than 
minutes (Costa et al., 2006) corresponds to any grossly similar phenomenon reflected in 
SPN spiking. Since baseline was negatively correlated with intensity for both datasets, 
this may reflect a normal condition of SPN spiking changes (most strongly suggested by 
the WT dorsal negative baseline correlation on l-DOPA, unadjusted p < 0.0001). 
 
Furthermore, the significant 3-way interaction in the l-DOPA intensity dataset 
implies a “top-heavy” WT depth differential in terms of baseline correlations that in the 
Pitx3Null animals is significantly less different. Our explanation for such an 
unexpectedly complicated finding is only speculative. That a lower baseline will tend 
(whether or not significantly and even under drug-free or low-dose conditions) to have a 
stronger response and vice versa (higher baseline having less response) may be expected 
to differ between WT depths (again, whether or not significantly); although any open-
field electrophysiological responses to l-DOPA in WT mice are not known by this author 
in the literature, sensorimotor (i.e. dorsal, West, 1998) SPN spiking intensity reversing 
over time in the open field in WT as their exploratory behavior subsides might be one 
way this could happen. This “top-heavy” difference contrasted greatly with the Pitx3Null 
depth difference wherein non-dorsal responses more closely matched dorsal responses, 
 
The weaker depth difference in Pitx3Null mice evident in the significant 3-way 
interaction may indicate a few possibilities. Since both Pitx3Null and WT non-dorsal 
striata have some or full DA innervation, their different differences with respect to dorsal 
striatum likelier involves some non-DA-ergic effect above and beyond or even instead of 
supersensitive receptor stimulation; e.g. regardless of the origin of hyper-responsive 
SPNs (without being able to rule out non-dorsal SPNs as the initiators), the overall effects 
of DA deficiency on the negative SPN spiking correlation with baseline are reflected 
throughout the striatum. E.g. it could be the result of altered motor network processes 
recruiting otherwise quieter non-dorsal striatal regions once a drug effect has begun (as in 
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striatonigrostriatal loops in primates shown anatomically by Haber et al., 2000, or the 
split circuit hypothesis advanced by Joel & Weiner, 1994, also see Beeler et al., 2012 for 
network simulation, and Beeler et al., 2008 for Pitx3Null relevant results). Another 
possibility could be a developmental compensation, as slight as the non-dorsal DA loss, 
of the non-dorsal baseline correlation, ensuring more responsive SPNs (notwithstanding 
dorsal Pitx3Null motor effects of DA denervation being independent from development 
as shown in Li et al., 2015). Similarly any non-dorsal compensatory change 
(developmental or otherwise) may have an overall network effect that reinforces the 
baseline correlation in individual SPNs (although see Bamford et al., 2004) leading to the 
overall pattern observed. 
 
 
D1 agonist, SKF 81297 
 
Similarly parsing the significant 3 way interaction from D1 agonist response 
polarities, the WT tendency for a dorsoventral gradient of negative baseline correlation 
with rate increases to l-DOPA was significantly inverted in Pitx3Null mice. This may be 
evidence that lacking DA in the Pitx3Null dorsal striatum allows higher baseline SPNs to 
pathologically decrease activity in response to DA stimulation and\or makes some less 
direct contribution to reduce the likelihood (albeit possibly insignificantly on its own) of 
an increase in rate in the non-dorsal region.  
 
Also noteworthy in the D1 agonist polarity results is the genotype-depth 
interaction independent of baseline: a striking ubiquity of WT dorsal rate increases in 
response to a selective D1 agonist, SKF-81297. In contrast, Pitx3Null SPNs tended to 
decrease rate (approaching p = 0.05) in response to D1 agonism. This is weak evidence 
for D1 agonism supporting a rate decreasing role in DA-deficient SPNs. (Johansen et al., 
1991, Xu et al., 1997, Fienberg, 1998) 
 
This assertion is further supported by the 3-way interaction (i.e. including 
baseline as a covariate. Pitx3Null dorsal SPN response polarities to D1 agonism may be 
more sensitive to their baseline rates than those of WT SPNs given the ~ 7-fold stronger 
negative correlation (notwithstanding its own statistical insignificance) where acute D1 
agonism reached SPNs in an otherwise DA deficient context. This is supported by the 
significant Pitx3Null dorsal baseline correlation significantly stronger than non-dorsal 
(discussed below), which pattern was significantly inverted between genotypes 
(discussed above). Thus a preponderance of evidence supports a role for DA deficiency 
in dorsal SPN spiking decreasing in response to acute D1 specific agonism in behaving 
mice as has been shown in other preparations and species (anesthetized Ballion et al., 
2009, Tseng et al., 2004, and in vitro Nisenbaum et al., 1992, Johansen et al., 1991), 
especially if they have low baseline spiking. 
 
A WT control situation for response intensities to D1 agonism is expected to be 
different from that to l-DOPA. WT animals are known to respond to SKF-81297 with 
increases in locomotor activity (Xu et al., 1994, Xu et al., 1997, Usiello te al., 2000, Kim 
et al., 2000), albeit more reliably at slightly higher doses. Simultaneous 
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electrophysiological responses to systemic D1 (full, i.e. not partial) agonism are not 
known in the mouse literature, although anesthetized data have shown primarily 
significant decreases in spiking in ventral striatum using iontophoresis (Johansen et al., 
1991, Fienberg et al., 1998, Xu et al., 1997, also see Gonon note accompanying Gonon, 
1997 online).  
 
Electrophysiological responses in dorsal WT striatum to D1 agonism in vivo may 
be expected to decrease if partial D1 agonist SKF38393 may be compared to SKF 81297. 
Systemic administration of SKF 38393 did not differ from SKF 81297 in terms of 
rescuing elecotrophysiological metrics after DA-depletion (Tseng et al., 2004), and it 
resulted homogeneously in increases (both in-\significant) having no obvious baseline 
correlation in WT animals. (Xu et al., 2011) (Results from these last two studies are also 
noteworthy for their opposing results when D1 agonist was given to DA deficient 
animals; Tseng et al., 2004 found that SKF-81297 decreased spiking, whereas Xu et al., 
2011 found a statistically insignificant increase; thus expectations for Pitx3Null dorsal 
SPNs responses to D1 agonist are less clear.)  
 
Our data showed a genotype difference in baseline correlation with response 
intensity; stronger specifically in Pitx3Null mice. WT animals showed responses for 
which we made no planned comparisons for checking against literature expectations, 
although there was an overall baseline correlation for both genotypes, which suggests a 
perhaps unexpected result given no previous reports. Nonetheless, Pitx3Null response 
intensity correlations with baseline spiking were significantly stronger. If WT data 
control for D1 receptor stimulation enhancing response intensities through a network 
effect (due possibly to extra-BG D1 receptor stimulation) that favors low-spiking SPNs, 
then we may interepret the remainder of the genotype difference in this metric to the 
contribution of super-sensitized D1 receptors. 
 
A similar explanation for genotype's main effect in the l-DOPA intensity dataset – 
i.e. behavior-relevant WT spiking – may underlie the lack of such an effect in the D1 
agonist response intensity dataset; to the extent that WT mice respond behaviorally to 
SKF 81297, their motor network activity (including SPN spiking) should change 
accordingly. If this involves any changes in SPN spiking intensity (increasing or 
decreasing), then as intensities approach those of the Pitx3Null animals, slighter genotype 
differences become more difficult to detect in such highly variable data. This may 
indicate the need for a more sensitive metric (or alternatively much more data) in order to 
show a reduced difference, which is compatible with results from Xu et al., 2011: no 
effect of DA deficiency in the responses to D1 agonist due to an insignificantly higher 
spiking increase in paraquat/maneb-treated rats compared to controls.  
 
Indeed, given the intense D1 and D2 receptor expression in SPNs (Levey et al., 
1993, Yung et al., 1995) and inherently less motor-inducing effect of D2-SPN stimulation 
during l-DOPA (Li & Zhou, 2013, Bateup et al., 2010, Darmopil et al., 2009), more 
intense changes in spiking are expected following DA depletion. (Murer & Moratalla, 
2011), but without a way to specify which receptors on which cells will be stimulated and 
in what network context, assumptions are made instead of controlling for these variables: 
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e.g. D1 receptor stimulation having its most intense effect directly at SPNs, especially 
DA-deficient SPNs, or contributions of receptor stimulation being distinguishable 
between genotypes on a background of more motor network activity than simply 
glutamatergic cortical input. Interpreting a receptor contribution to significant SPN 
spiking changes above and beyond WT responses as a mechanism underlying DA-
deficient striatal network activity during behavior will thus require future studies: these 
should control for changes in intrinsic, afferent, recurrent, and/or reentrant network 
activity (ideally minimizing SPN spiking variability) so that any aspect of the hyper-
responsive spiking in DA deficient SPNs can be isolated to differences in receptor 
activity. 
 
 
Striatonigral cell response intensities 
 
The canonical rate model developed by Albin and Delong (Albin et al, 1989 
Wichmann & Delong, 1996) predict that DA receptor supersensitivity in the DA 
denervated context would allow DA agonists to lead to electrophysiological (and 
ultimately behavioral) changes via differential dopamine receptor activation in in-/direct 
pathways. Specifically D1 receptor signaling on D1-SPNs (which is coupled to G-alpha-
olf cascades) would be activated to an unusually high degree, which would be expected 
to exaggerate D1-SPN spike firing simultaneously unusually strong D2 receptor signaling 
(Gi-coupled) would be expected to decrease the spiking of D2-SPNs. Together, these 
cellular responseswould yield an overall increase in motor activity, more so in the 
parkinsonian condition than the usual condition. However, this simplified explanation 
superficially conflicts to some extents with studies reporting increases in the activity of 
both D1- and D2-SPNs during movement (Cui et al, 2013) as well as those reporting 
spiking decreases in vast majorities of SPN recordings during free movement and local 
application of specific DA agonists (Inase et al., 1997; Kiyatkin and Rebec, 1997 and 
1999) and specifically in antidromically identified SPNs during movement induced by 
systemic DA agonism (Ryan et al, 1989). This could conceivably be due to task-relevant 
cortical glutamatergic input as a prerequeisite for spiking at all (Mink, 1996, Beeler et al, 
2012, Friend & Kravitz, 2014; also see Discussion). 
 
Antidromically identified cell response intensity differences –polarity being 
precluded from testing given so few decreases in rate– between genotypes, while not 
significant in a strict statistical sense, appear to follow rate model expectations and our 
hypothesis that Pitx3Null SPNs are hyper-responsive in terms of intensity to both l-
DOPA and SKF 81297. However, a major problem with this interpretation emerges when 
considering the possible significance of baseline correlation with response intensity so 
evident in the other datasets –not tested in this dataset due to such a strong correlation of 
baseline with genotype and our desire to minimize model complication; Pitx3Null 
baselines are significantly lower than WT, and their responses to both drugs appear to be 
exaggerated over WT cells. It is thus conceivable that the negative correlation of 
baselines in other datasets (for SPNs from both genotypes) holds here, which (given 
baseline differences between genotypes in this dataset) may be responsible for the 
response intensity difference between genotypes; i.e. this would make it easy to confuse a 
 66 
significant effect of baseline on striatonigral response intensities with a significant effect 
of genotype. Distinguishing this possibility would require more identified cells having 
higher baselines in Pitx3Null animals and more having lower baselines in WT animals. 
Yet if the current dataset is representative of the expected ratio of such SPNs, then this 
experiment appears to be prohibitively difficult since, given our technical capabilities, 
one to two identified cells per month was the expected rate of acquisition; having two 
low baseline cells per 8 WT alone would thus require ~5 times the investment, in order to 
acquire an n of even just 4 of these less likely baseline cells (let alone considering animal 
N or the fact that all Pitx3Null striatonigral cells had low baselines), i.e. a single “rare 
baseline” identified cell per 3-6 months. 
 
Although inconclusive, these response intensity data still suggest that Pitx3Null 
DA-deficient striatonigral cells are likely hyper-responsive to D1-receptor stimulation 
whether that be due to a baseline difference and\or receptor supersensitivity. As with 
interpreting other datasets, any motor network contribution to the response is still 
difficult to parse from the direct effect of D1 receptor stimulation. Thus, overall only 
behaving animal experiments recording from SPNs having identified baseline rates and 
certain receptor expression as well as isolating DA receptor stimulation as locally in time 
and space as possible may elucidate differences between lesioned and intact striata of the 
in vivo pharmacological effects of DA agonism on SPN spiking. A combination of 
antidromic identification with optogenetic and/or designer receptors activated exclusively 
by designer drugs (DREADDs) coupled with iontophoretic agonist drug injection during 
systemic antagonist drug application may be most suitable for this purpose. 
 
 
Depth differences 
 
Although depth made a (different) difference to the response polarities in both 
genotypes, differences in response intensities expected by our hypothesis were notably 
lacking except in 3-way interactions. Dorsal depth was associated in both genotypes with 
a more intensely negative correlation of baseline with l-DOPA response polarities, and 
the same held true for D1 agonist response polarities in at least Pitx3Null animals 
(according to planned comparisons). For response intensities, we expected depth to 
interact with genotype in order to differentiate SPN rate change intensities only in 
Pitx3Null dorsal from non-dorsal and from all WT; instead it was useful in distinguishing 
an inverted baseline correlation between genotypes (wherein Pitx3Null non-dorsal SPNs' 
response intensities were unexpectedly higher) for l-DOPA and in determining that 
Pitx3Null dorsal baseline correlations were stronger only than WT dorsal baseline 
correlations in the D1 agonist dataset. 
 
In the case of l-DOPA, past research indicates that given 1:1 D1:D2-SPNs in the 
dorsal striatum (Valjent et al., 2009), the original rate model predicts 1:1 
increasing:decreasing polarities (and thus no significant group differences) in either 
genotype, regardless of whether or not they respond to l-DOPA. Thus, the difference 
between response polarities dependent on baselines is unexpected by the rate model 
(since no known results quantify a significant difference between SPN subtypes based on 
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purely electrophysiological properties in awake animals [Friend & Kravitz, 2014], e.g. 
long-term baseline spiking). This baseline correlation depending additionally on depth is 
even further unexpected given (again) the lack of results quantifying differences between 
SPN subtypes in their electrophysiological properties (Friend & Kravitz, 2014). Either 
the rate model must be modified to account for an as yet unproven correlation between 
baseline spiking and SPN subtype, or the model must be updated with another factor 
having primary influence over spike rates (likely thalamic and cortical glutamatergic 
input, Mink, 1996, Beeler et al., 2012). 
 
Only 4 of 33 dorsal WT SPNs (from 6 animals) decreased rate responding to a 
specific D1 receptor agonist; this is exceedingly difficult to reconcile with the rate 
model's predictions without relying on other factors to explain the phenomenon (e.g. the 
primacy of cortical input, Beeler et al., 2012, Neve, 2010). Thus, overall polarity results 
in WT imply – aside from an otherwise paradoxical mechanism through which D1 
agonist inhibited spiking in so many non-dorsal SPNs – SPN subtype independence from 
response polarity. The likelihood that not one of these were D2-SPNs is very low (one 
sample proportion z-test p < 0.0001), given the knowledge of the ~1:1 ratio of SPN 
subtypes occurring in striata from many species (Valjent et al., 2009). Excluding 
“insignificant” responses (based on comparing mean rates from 10 or 100 second bins 
pre- and post-drug) in order to distinguish from the rest of the SPNs those having 
statistically meaningful increases made the proportion indistinguishable from 50:50; 
however this approach also uncovered a SPN that significantly decreased mean spiking 
*(data not shown). This result begs the question of what to expect when stimulating 
specifically D1 receptors in WT, let alone DA deficient, striatum; thus, the utility of this 
metric for identifying SPN subtype is dubious and the depth difference considerable 
enough to require inclusion of other factors predicting rate change polarity. 
 
Of particular note considering depth results from all datasets is that Pitx3Null 
animals only showed a significant effect of depth in terms of response polarity to D1 
agonist, i.e. despite our expectations, depth did not play any role in terms of response 
intensity differences regardless of drug without comparison to an exaggerated WT depth 
differential of baseline correlation (l-DOPA) or restricting baseline correlation 
comparison to dorsal regions between genotypes (D1 agonist). This is born out in 
(Figures 18-21) where occasional non-dorsal Pitx3Null SPNs have responses apparently 
as intense as the dorsal SPNs. The supersensitized receptor explanation for such 
responses would be directly controverted unless these errant SPNs had baselines lower 
than expected for their response; such cells were not rigorously identified, but the few 
most obvious had baselines not noticeably lower than their dorsal counterparts (also 
reflected in the overall results). As explained in the genotype differences section (and 
more below), results involving the 3-way interaction that included depth differences 
suggest that altered Pitx3Null motor network functions specific to depth may underlie the 
effects of DA restoration in the Pitx3Null dorsal striatum compared to WT dorsal 
(enhancement) and Pitx3Null non-dorsal (comparability) of the negative correlation 
between SPN baseline and response intensity. 
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Overall, aside from the particular relevance of depth in the case of the Pitx3Null 
DA denervation gradient, these results might fit into the literature in terms of task-
dependent functional organization of the striatum, provided baseline correlation with 
response intensity is a natural electrophysiological phenotype of SPN spiking subject to 
the influence of DA denervation and restoration, which is evident in our data (unplanned 
comparison in WT dorsal striatum on l-DOPA). West (1998, also see West et al., 1990) 
demonstrated more than half (and up to 100%) of rat dorsolateral striatal (encompassing 
approximately the dorsal and lateral quadrant of the striatum) SPNs firing sensorimotor 
related spikes. Graybiel lab studies in primarily dorsolateral (approximately the dorsal 
and lateral striatal quadrant) striatum depend on such sensorimotor relationships and 
define their SPN subsets in terms of task-relevance (Kubota et al., 2009, Hernandez et al., 
2013, Smith & Graybiel, 2013); they also showed (Xu et al., 1997) that the D3 receptor 
mutant mouse's increased locomotor phenotype is likely due to electrophsyiological 
changes somewhere other than ventral striatum.  
 
Combining insights from both depths, Belin & Everitt, 2011, showed that 
chemically inactivating dorsal striatum after a ventral striatal lesion in the opposite 
hemisphere decreased drug-seeking behavior; they interpreted this effect as an 
interruption of habit expression. In Pitx3Null mice specifically, Beeler et al., 2008 
showed that the dorsal DA lesion precludes a normal locomotor response to cocaine and 
subsequent sensitization to repeated exposure but that ventral striatal functions like 
conditioned place preference and cocaine sensitization of sucrose preference were spared. 
Altogether then, – and to the extent that our non-dorsal data represent ventral striatal 
function – if indeed Pitx3Null DA denervation prevents the DA-dependent transfer of 
ventral striatal (goal-directed) SPN spiking to dorsal (stimulus-response habit-related) 
spiking, then sensorimotor activity in the dorsal Pitx3Null striatum on l-DOPA or D1 
agonist could be expected to reflect something akin to spontaneous formation of motor 
habits: provided this phenomenon is enacted preferentially through SPNs having lower 
baselines – possibly striatonigral SPNs –, then this interpretation matches our results 
showing comparable activity between Pitx3Null depths. 
 
 
In literature context 
 
l-DOPA, the most common long term dopamine replacement therapy for PD, 
relieves the brady- and hypokinesia of parkinsonian patients (i.e. increases self-initiated 
motor activity) and is eventually associated with motor complications referred to as l-
DOPA-induced dyskinesias (Olanow, 2009). These motor effects of acute DA agonism 
are expected to be mediated by DA receptors located where DA's absence has had the 
opposite effect of slowing and limiting self-initiated movement. “By what striatal 
electrophysiological mechanisms does l-DOPA have a motor stimulating effect?” is the 
overarching question that we hope to further answer. 
 
More specifically, what effect does l-DOPA given in the context of DA 
deficiency have on SPN spiking? SPNs are the largest subpopulation of BG neurons and 
are uniquely positioned to integrate cortical input and translate that information to output 
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nuclei (Mink, 1996, Beeler et al. 2012, Friend & Kravitz, 2014); furthermore, they 
express dopamine receptors heavily (Levey et al 1993; Yung et al 1995), and at least D1-
SPNs show supersensitized receptors in parkinsonian humans and rats (Corvol et al, 
2002; Tong et al, 2004; reviewed in Herve et al, 2011). These receptors are located in the 
DA-denervated BG (an important network for motor control, Alexander et al., 1991) of 
PD and of l-DOPA sensitive animal models, e.g. Pitx3Null mice, 6-OHDA-lesioned 
rodents. Because the absent nigrostriatal neurons would otherwise innervate only the BG 
to an appreciable extent, DA from l-DOPA is regulated as usual in DA sufficient brain 
areas. Thus DA deficient BG DA receptors are acutely stimulated upon l-DOPA 
administration by its neuroactive metabolite, DA, and the subsequent movements must, 
by definition, be the consequence of a spike output change initiated in any of the subjects' 
neurons/networks that cause motor activity (in this case the BG motor circuit since all 
self-initiated animal movement originates in the spiking of such neurons/networks (Nolte, 
2002). Taken together, motor activity induced by l-DOPA is often presumed to 
precipitate from the action of DA on the spiking of cells in the BG network expressing 
DA receptors in the context of DA deficiency (such a context including 
supersensitization, plastic changes from DA loss, dysregulated DA trafficking, etc.). But 
where is the evidence? 
 
 
In defense of the causal D1-SPN hypothesis 
 
D1 SPNS may be the specific cells at which l-DOPA's effects are necessary for its 
acute effects on behavior according to the following rationale. The DA that l-DOPA 
yields stimulates primarily DA receptors, by definition. However, l-DOPA treatment (i.e. 
usually combined with a peripheral decarboxylase inhibitor, e.g. benserazide or 
carbidopa) has shown no detectable behavioral effect in DA-sufficient mice (likely due to 
their sufficient central DA uptake and metabolism still in place, Abercrombie et al,1990, 
Kim et al., 2000). l-DOPA's motor stimulating effects (both normal and abnormal or 
dyskinetic) in the chronically DA deficient BG must depend heavily on changes in 
DA trafficking and/or receptors,i.e. likely to be necessary and sufficient (at the receptor 
scale) to cause what are known as LID (l-DOPA-induced dyskinesia) in patients, and 
abnormal involuntary movements in rodents.  
 
The possibility that network plasticity in response to DA denervation could 
preclude all of these effects is evident when one considers the myriad potential 
hypotheses formed from the wealth of relevant data: altered DA trafficking (e.g. Lee et 
al, 2008), compensatory mechanisms (e.g. Iravani et al., 2012), effects on output 
structures and downstream (e.g. thalamo-cortical changes, simulated or otherwise, Rubin 
et al, 2012, Hauptmann & Tass, 2010), all acting on relatively sparsely elucidated 
mechanisms in the WT striatal context (e.g. D2 receptors filtering low-activity synapses 
in Bamford et al., 2004, DA agonists affecting all subsets of neurons in all behavioral 
contexts in Inase et al, 1997, Isomura et al., 2013). Nonetheless, our data allows 
refinement of the canonical rate model and challenges to it owing to the relative 
inattention to striatal electrophysiological effects of DA pharmacology in awake animals. 
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Based on the evidence reviewed below, it is put forth that D1-SPNs are the 
likeliest effectors underlying motor activity induced by l-DOPA (i.e. at least a necessary 
interface between the DA receptors that l-DOPA stimulates and the behavior that it elicits 
in the context of chronic DA deficiency). Alternative hypotheses concerning l-DOPA-
induced behavior may exist; only manipulations at the receptor, cell and network levels 
conducted in as isolated a manner as possible will validate or disprove their differential 
outcomes with certainty. However, using our current techniques, this is not possible, thus 
we rely on literature support for this keystone of our rationale, that D1 receptors 
expressed on D1-SPNs are the primary causative agents in l-DOPA's behavioral effect in 
Pitx3Null mice. We support this hypothesis by bolstering the weak electrophysiological 
data for it (and implicitly for its underlying canonical rate model interpretation). (A 
similar explanation of D1-SPNs causing AIMs may be found in Murer & Moratalla, 
2011.) 
 
Because of the lack of known extra-BG (i.e. cortical, thalamic, peripheral, etc.) 
DA receptors to supersensitize or become subject to dysregulated DA trafficking while 
their DA inputs remain intact, then DA receptors outside of the BG are exceedingly 
unlikely to underlie this phenomenon by virtue of their otherwise intact sensitivity and 
homeostatic DA context. All PD models have DA deficiency well-restricted to some 
portion of the BG. (However, consider Halje et al's, 2012, finding of cortical 
dopaminergic interruption of l-DOPA-induced abnormal involuntary movements and less 
DA terminals in cortex ipsilateral to 6-OHDA lesion as well as Rubin et al's (2012) points 
about thalamic and cortical DA loss.) 
 
Because l-DOPA metabolism yields DA, a non-specific DA receptor agonist, both 
supersensitized D2-family and D1-family receptors may be stimulated to cause the 
observed motor behaviors. However, much evidence that supports D1- over D2-SPNs 
playing a necessary role comes from Darmopil et al., 2009, Bateup et al., 2010, Li&Zhou, 
2013 and others: 
 
• Darmopil et al, 2009, used genetic inactivation of D1 or D2 receptors in 6-OHDA 
lesioned mice in order to show that D1 (and not D2) receptors played a necessary 
role in l-DOPA-induced abnormal involuntary movements. It is noteworthy that 
D1 receptors aren't known to be localized in BG neurons other than D1-SPNs 
(Kreitzer, 2009; Smith & Villalba, 2008; Rommelfanger & Wichmann, 2010) 
except for a subset of non-bursting subthalamic nucleus (STN) cells, which (as 
the rest of the STN) more strongly express D5 receptors (the other receptor in the 
D1 family) and express D5 receptor mRNA much more strongly than that of all 
other DA receptors;  
 
• Bateup et al, 2010, showed that selective~70% reduction in D1-SPNs of DARPP-
32 (a downstream effector of DA receptors) abolished l-DOPA's motor effect; on 
the other hand they showed that ~40% DARPP-32 reduction in D2-SPNs had no 
effect on l-DOPA-induced abnormal behaviors but did reduce behavioral effects 
dependent on D2-family-receptors (e.g. haloperidol-induced catalepsy);  
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• Li & Zhou, 2013, found that increases in horizontal and vertical movements 
Pitx3Null to D2-family agonist, ropinirole, contrasted considerably with that of l-
DOPA whereas D1-family agonist, SKF-81297, resembled l-DOPA's behavioral 
response profile much more comparably.  
 
Taken altogether, these studies strongly suggest that D1-SPN spiking is a 
necessary (and likely sufficient, given the isolation of supersensitized D1 receptors) 
antecedant at the cell level for acute l-DOPA-induced behavior.  
 
The evidence discussed in favor of this hypothesis thus far is substantial, however 
single-unit recordings of SPNs during l-DOPA-induced abnormal behaviors should 
correlate the supposedly causal SPN activity to the resulting behaviors on a comparable 
time scale, lending it more credence, yet precisely these recordings are extremely sparse 
in both primates (not one as of Boraud et al., 2002, one thereafter Liang et al., 2008) and 
rodents (Iversen, 2010, pg. 438; Kish et al, 1999, Chen et al, 2001, Halje et al, 2012.) 
Anesthetized animals have been studied in much more detail and their SPNs for the most 
part show responses similar to those in awake animals but having drastically different 
firing rates than during waking (Kish et al, 1999) and are therefore of questionable 
fidelity to waking circumstances, especially in the sensorimotor-related dorsolateral 
striatum (West, 1998.) 
 
Pitx3Null mice are an appropriate model of the motor activity induced by l-DOPA 
for many reasons. Their l-DOPA-induced motor activity (van den Munckoff et al, 2006), 
which is absent in WT animals (Ding et al, 2007), is responsive to anti-LID therapies, 
amantadine and buspirone (Francardo and Cenci, 2014), and molecular markers of DA 
receptor supersensitivity similar to l-DOPA-induced dyskinesia models arise in the 
Pitx3Null striatum subsequent to l-DOPA treatment (Francardo & Cenci, 2014). 
Together, these indicate interactions between the conceptual levels of behavior and 
receptors similar to patients and other animal models concerning the l-DOPA sensitivity 
that arises after DA deficiency. Finally these mice avoid the pitfalls of toxin-lesioned 
models (e.g. reproducibility of lesion, dependability of response to l-DOPA across 
animals; Li & Zhou, 2013). 
 
Clearly one problem with using an SPN's change in spiking to characterize 
receptor expression (and thus projection target as well as putative network contribution) 
is the ambiguity of responses to DA. Whereas D1-SPNs are expected in the standard 
model to increase rate in response to stimulation of D1 receptors according to their 
downstream effectors, and D2-SPNs should show the opposite effect due to D2 receptor 
stimulation, the ratio of responses seen in this study and others (e.g. Ruskin et al., 1999) 
imply that further methods are required in order to distinguish D1- from D2- SPNs in 
vivo, let alone to distinguish the opposite responses that further parse each of those 
subpopulations since their pharmacological responses could be so similar (e.g. given our 
results or those of others like Inase et al., 1997, Claussen & Dafny, 2015).  
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Ryan et al. 1989 tried to disambiguate responses to amphetamine in healthy, 
mobile rats by antidromically activating putative D1-SPNs (as we have done here for the 
Pitx3 mutant mouse), but many of the identified cells responded unexpectedly; they 
showed general decreases in firing over tens of minutes and specific decreases using 
behavioral periods matched pre- and post-drug exposure (akin to a “behavioral clamp” 
experiment , e.g. spiking considered only during head bobbing, only during sniffing, 
etc.), although some did increase. Rebec, 1998, tried iontophoretic application of DA 
simultaneously with glutamate into the striatum of unrestrained rats in order to provide 
more support for the hypothesis that motor-related SPNs were responding to drug 
(amphetamine in his previous studies), and not to other motor-related brain activity, 
cortical input or sensory feedback among others (for some of which he performed 
separate studies to rule out their possibilities).  
 
In awake rats, Kish et al, 1999, observed that SPN spiking increased on average 
after apomorphine (a mixed D1/D2 agonist) in 6-OHDA-lesioned striata whereas 
apomorphine was without effect on the respective unlesioned striata and unilateral saline 
control animal striata. They concluded that firing rate sensitivity to DA was increased in 
DA-deficient SPNs. Chen et al, 2001, saw the same dose of apomorphine, in contrast, 
decrease rates in lesioned striata on average (whose baseline rates were already increased 
from control). They concluded that DA's function was inhibitory to SPNs and may 
thereby affect action selection. However, neither study distinguished cells having 
different rate response polarities; thus, by conflating rate increases with decreases when 
averaging all rate changes, mechanisms more refined than homogenous rate coding 
across cells (known to be of different subtypes) were precluded from commentary. 
Accordingly, Halje et al, 2012, reported that l-DOPA injection after unilateral 6-OHDA 
lesion indeed leads to both increases and decreases in SPN spiking, but conclusions were 
focused entirely on an oscillatory cortical activity contributing to dyskinesia. Each of 
these studies left SPNs unidentified, which weakened their explanatory power, thus 
limiting clinically relevant interpretations (especially those possible within the canonical 
framework). 
 
The resulting dichotomy of responses to D1 agonist herein (in-/decreases 
exemplified best in Figures 18-21) was therefore not unexpected (also see other studies 
classifying SPNs according primarily to task-relevance before or in addition to DA 
response, e.g. Hernandez et al, 2013, Inase et al., 1997). However, promisingly, SPNs in 
Pitx3Null animals, both increasing and decreasing, responded more intensely 
accompanying motor activity induced by l-DOPA. 
 
Inasmuch as our conclusions are similar, our results are in agreement with Kish et 
al. 1999, in the rat 6-OHDA model of LID. We also extend their results in the following 
ways:  
 
• by the presence of a different style of induced abnormal behavior –“three-paw 
dyskinesia” in Pitx3Null (Ding et al, 2007) instead of contralateral rotation– due 
to the different DA lesion in Pitx3Null mice (Li et al, 2015);  
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• by antidromically identifying putative D1-SPNs as being particularly and 
significantly affected by DA depletion and likely by DA agonism in that context. 
 
To this last point, although there is no compelling evidence from awake, behaving 
animals that specific activation of D1 receptors causes strictly, or even primarily, 
increases in D1-SPN spiking (as opposed to more complex, modest, or other unexpected 
effects on SPN spiking), such responses are expected in at least some subpopulation of 
D1-SPNs secondary to D1 receptor stimulation. This is especially so given concurrent 
supersensitization of DA receptor signaling after DA depletion, all based on the 
prediction of the canonical rate model (also supported via parkinsonian primate BG cell 
responses to DA agonists, Boraud et al, 2002, and many rodent studies, Ruskin et al, 
1999, Waszczak, 1984, Iversen, 2010, pg 438) and some in vitro rodent PD model data 
(Plotkin et al, 2011). From a purely electriophysiological persepctive, because optical 
stimulation of D1-SPNs is known to activate behavior, they would be expected to 
increase firing based on their being positioned conceptually at the scale between DA-
denervated, supersensitized DA receptors and behavior induced by l-DOPA in the 
putative causal pathway outlined above.  
 
Two WT identified SPNs (not shown since they were below the threshold for 
being considered dorsal) decreased activity after D1 agonism; these do not fit the 
canonical rate model but warrant comment since they have been seen before. They may 
be disfacilitated (Mahon et al, 2006) by a behavior-related, silencing of glutamatergic 
inputs originating in the cortex and thalamus, discussed more below. Alternatively, in the 
case of l-DOPA injections D2 receptor agonism may silence these SPNs (Cepeda & 
Levine, 1998; Plotkin et al, 2011). Although supported in non-waking animal studies and 
in vitro, these interpretations remain speculative. 
 
Rate-decreasing SPNs identified as D1 expressing (e.g. Fig. 7, Ryan et al, 1989) 
are difficult to account for because their spike activity in relation to motor behavior is 
exactly opposite of that expected based on the canonical rate model; thus this 
subpopulation warrants special attention. Its existence alone is sufficient evidence to 
warrant reconsidering the model, which has been easily resolved by adding one more 
level of complexity: that of behaviorally relevant glutamatergic inputs. Behavioral 
relevance may be built into the topographical nature of the corticostriatal projections: a 
principled simulation by Beeler et al, 2012, endowed these projections with the ability to 
facilitate SPN spiking in a task-dependent way. Thus relevant spiking in the cortex was 
necessary before DA could exert its effect, and the model accounted for DA effects they 
observed in vivo. In other words, one possible explanation for the motor-relatedness of 
any single SPN presupposes glutamatergic input sufficient to cause SPN spiking before 
DA may be allowed to have its canonical rate effect on spiking. 
 
In vitro, other unpublished results from our lab indicate that dorsal Pitx3Null D1-
SPNs are more sensitive to D1 agonism in terms of excitability and current pulse-induced 
firing. Observing these results in a preparation lacking much cortical and thalamic 
glutamatergic input is even more impressive considering that such input has been shown 
to be necessary for not only SPN spiking (Surmeier et al. 2007) but the D1 agonist effect 
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as well (Plotkin et al, 2011). Considering this point in conjunction with the findings that 
glutamatergic inputs are the primary source of glutamatergic excitation to SPNs 
(Surmeier et al. 2007), then it stands to reason that specific cortical/thalamic activity 
gives way to specific striatal activity in a topographic manner and that this topography 
may underlie the specialized functions of specific locales of striatum (Beeler et al, 2012). 
 
 
Discussion of Striatal Fibers of Passage Being Mistaken for FSIs 
 
Given the width of these waveforms compared to SPNs, and their rates, they 
would most likely be considered FSIs (PV+ GABAergic interneurons). Even a more 
detailed look at their patterns during wake and sleep might support that conclusion. 
However, while the degree of evidence supporting each cell's identity differs, their 
matching characteristics nonetheless bolster the hypothesis that they are neither 
interneurons nor SPNs.  
 
The results shown are very unlikely to be orthodromic spikes from the midbrain 
since collisions would extremely unexpected by any known mechanism in that case; the 
consistency of a precise temporal sequence of stimulus then response, the collisions, and 
the refractory period all point to these responses as axonal spike propagation.  
 
Myelinated cortical axons exhibit conduction velocities on the order of high 
singles to tens of meters per second in cats (Jinnai & Matsuda, 1979) and macaques 
(Turner & Delong, 2000). Sensorimotor cortical axons course more densely in the 
dorsolateral striatum. (Wilson, 1987, Kubota et al, 2009, Schwarz & Chakrabarti, 2015) 
Given the only known major projections to striatum that would approach the stimulating 
electrode placed in this study, these fibers would presumably be of cortical origin. In 
summary, these characteristics (widespread instances of bundled cell processes projecting 
through the striatum to or beyond midbrain and having conduction velocities in the single 
meters per second) increase the candidacy of the cortex as the origin of these fibers.  
 
 
Conclusions 
 
Overall, we have bolstered heretofore weak electrophysiological data supporting 
the hypothesis (modeled on the in/direct pathways concept) that hyper-responsive SPNs 
mediate motor activity initiated via DA-deficient SPN DA receptor signaling by showing 
clear distinction in SPN spiking changes between dorsal WT and DA-denervated 
Pitx3Null striatum in response to DA agonists. Furthermore, where DA denervation is 
chronically <1% that of WT (Li&Zhou, 2013), baseline striatonigral spiking is much less 
than where there is full DA innervation in the complementary WT dorsal striatum. Fitting 
our results into the context of previously published literature concerning the causes of 
motor activity induced by l-DOPA, we posit that lowering l-DOPA dose reduces 
dyskinesias but at the cost of some efficacy in restoring motor activity to the otherwise 
parkinsonian state. This may imply that l-DOPA's induction of both normal and 
 75 
dyskinetic motor activity may be inextricably linked to a common pharmacological 
mechanism involving DA signaling in the BG. 
 
Furthermore, while the given evidence for fibers of passage being mistaken as 
striatal FSIs does not irrefutably prove the identity/somatic location of the units, it 
nonetheless casts strong doubt on the validity of the assumption that all striatal units 
having narrow waveforms and high rate are interneurons. Previous findings may thus be 
reconsidered, and future reports more cautiously interpreted in order to potentially 
resolve apparently contradictory results. This may also represent an opportunity to 
improve the utility of striatal recordings; e.g., upon improving this technique's reliability 
and identifying these fibers, one may be able to improve the corroboration of striatal data 
with somewhat coextensive extrastriatal projection cells in real-time without requiring 
extra electrodes. Future experiments should attempt to distinguish in vivo identification 
criteria between FSIs and fibers of passage through the striatum, most likely cortical. 
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